Other,systematicSearch
Other,antibody-anchoredMagneticBeads
Other,bayesianNetworkMeta-analysis
Mastectomies,bilateralTotalMastectomies
Other,mutationCarriers
Other,decision
Other,otherFactors
Other,revealed
Other,collectedSignatures
Other,generalHealth
Other,factors
Obstacle,block
Other,metastaticAdenocarcinomaFeatures
Other,currentCancerResearch
Other,recruitment
Lifestyle,responseRate
Other,only20Percecnt
Relapse,betterPrognosis
Other,-69PercecntTo+239Percecnt
Other,differentialDiagnosisInPatientsWithHistoryOfBreastSurgery
Other,associatedWithPfsAlthoughAtExtent
Other,threeDifferentClusters
Other,scarceReports
Sarcomas,high-gradeSarcomas
Other,breastCancerYoungerThan45Years
Dysplasia,regressionModel
Other,differentPhenotypes
Other,population-basedStudies
Other,health
Other,cutoffValue
Mutations,Mutations
Incorporation,workAbility
Other,female
Other,smallPopulation
Other,1984
Other,high-riskWomen
Other,solidTumor
Other,family
Other,incorrectDiagnosis
Other,compactSynchrotronSources
Other,similarTowaveletFilter
Other,comparedToThoseWithPregestationalBreastCancer
Document,exposure
Other,oneRandomlyAssignedToAxillaryDissection
Other,138Patients
Other,decision-making
Other,diagnostics
Polymorphisms,vdrPolymorphisms
Other,shouldPerformedInAtRisk
Other,Downregulation
Disease,elevatedLesion
Other,prospectiveInformationAboutCharacteristicsOfWomenWithLungCancer
Other,concurrentNeuroprotectiveDrugTherapy
Other,obtained
Other,otherSites
Incorporation,retrospectiveStudyOfPatientsWithCa-vte
Other,extensiveExploration
Other,thenExploredByRocheCobasE601
Other,affected
Other,uncommon
Incorporation,study
Other,breastCancerRisk
Other,opticalAbsorptions
Other,13-hDailyOvernightFast
Other,464Percecnt
Other,pool
Other,inductionOfFamily
Other,93Percecnt
Other,inclusion
Other,91PercecntInPatientsWithBreastTumors
Other,them
Mother,prominentSourceOfCancerMortalityInWomenThroughoutWorld
Other,MRI
Other,specificAreas
Other,Information
Other,aimed
Other,paper
Other,about30Percecnt
Appearance,variedDegreesOfStructuralComplexity
Other,furtherImaging
Other,indicative
Incorporation,chicagoStudy
Other,itsDifficultEarlyDiagnosis
Other,advancedComputationalSystems
Other,evenSubgroupOfPatientsTreatedWithRituximab
Interval,longPeriodOfTime
Complications,acuteComplications
Other,rnaOligonucleotides
Other,thenLinkedToTownshipFemaleBreastCancerIncidenceRateIn2000s
Other,comparedBetween2GroupstheApatinib
Other,shouldTested
Other,recentStudies
Appearance,theirAbility
Other,betterUnderstanding
Other,detailedAnalysis
Resistance,shouldOvercomeBeforeClinicalApplication
Complications,lateComplications
Other,uniqueProperties
Document,higherBalfContent
Pediatric,pediatricPatients
Other,phosphatase
Hyperglycemia,effectOnBoneRemodelingThroughItsReceptor
Other,detectionOfCancer
Other,essentialRole
Provision,lastFourDecades
Other,145Percecnt
Other,relationshipBetweenNlr
Other,highHeterogeneity
Disease,tataMemorialCancerHospital
Other,preparedRespectively
Other,systems
Other,importance
Other,visualInspection
Other,sentinelLymphNodeBiopsy
Other,stained
Other,variousImportantFunctions
Other,total
Other,ssessed
Other,newDesignDouble-layerCapacitors
Other,consequentlyHaveDeveloped
Other,Disease
Other,positivelyAssociated
Other,routine
Other,fiveYearsPosttreatment
Other,sister
Other,henceCurrentlyOnlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
Other,dose-dependentReduction
Other,unreported
Other,thriceHigher
Disease,boneTumors
Other,S7
Collision,impact
Other,haveDeveloped
Other,assessedPreoperatively
Other,attentionToSpecialGroups
Other,analysis
Guidelines,internationalGuidelines
Other,driven
Other,bestAvailableEvidence
Other,redoxStatus
Probe,stressProbe
Disease,cancer
Markers,specificMethylationMarkersImportantForCrcDetection
Other,fastingBlood
Lifestyle,responseFollowingAdministrationOfNeoadjuvantChemotherapy
Other,4.71
Other,inBreastTumorsKnownAsBreastCscs
Other,immunohistochemistry
Other,expressedCircularRnas
Other,pre-diagnosticObesity
Other,groups
Other,geneticPredispositionForCancer
Other,efficientlyCross-linked
Other,imperative
Interference,complication
Relapse,mitoticExitOfPtx-pretreatedCells
Other,warranted
Other,furthermoreRestricted
Other,mammographicBreastCancerScreening
Other,collectedFromElectronicHealthRecord
Other,Using
Other,mostStudies
Other,humanBreastNeoplasmsWithDeregulationOfSeveralMirnas
Other,12EventsAmong121Patients
Other,occurrenceOfTumors
Relapse,exit
Other,descriptive
Other,nowGreater
Other,inGrowth
Other,medicalDiagnosisOfBreastCancer
Other,youngerPeople
Other,cancer-relatedDeathInChineseWomen
Pediatric,shouldPerformedInPediatricPatients
Other,diverseBiologicalProcesses
Dysplasia,zero-inflatedPoissonRegression
Other,comparisonToCa15-3
Other,geneExpressionUpregulationInBreastCancer
Similarities,similaritiesOfInformationRequired
PET/CT,f-fdgPet/ct
Gene,vascularAdhesionProtein-1
Other,second
Other,hasProven
Other,novel
Other,backgroundTrastuzumab
Other,moreEffectiveTreatmentOfLungCancers
Infrared,researchLight
Disease,hypoxia
Appearance,significantDifference
Other,summarised
Other,resistantCells
Other,commonAdultCancers
Other,proteinS-100
Other,treatmentOfEuropeanPatients
Other,seValues
Distance,breastImageneologicalSurveillanceBeginningAtAge
Craniotomy,forPrecisionResectionUrgentInFieldOfDiagnosis
Interval,meanwhileBetterThanInCapecitabineGroup
Other,13Percecnt
Other,considerableNumber
Other,patient'sMedicalHistory
Other,generalRadiologistAboutSystemicDiseases
Other,treatmentOfBreastCancer
Isolation,feasibleCtcIsolationTechniques
Other,minimalRisksToNormalCells
Other,neonatal
Obstacle,thusWouldCrucialForApplicationOfPreventiveStrategies
Other,cytogeneticAnalysis
Other,emergingTechnology
Other,show
Other,alternative
Other,acquisition
Other,glut1Expression
Other,mutationsCarriers
Other,decreasedGrowth
Other,lessLikely
Other,initialTreatmentAfterWhich
Other,aim
Other,skeleton
Other,incrementalCostOfCop$251049
Other,limitedHealthSystemCapacities
Other,automatedAnalysisOfClinicallyRelevantHistopathologicFeature
Interference,intervention
Other,invasive
Other,relevant
Other,pax6promoterMethylation
Other,CRD42016048917
Other,roles
Other,SP
Other,bevelledEdges
Resistance,theirCytotoxicityAgainstTwoHumanTumorCellLines
Other,time
Provision,criticalScientificBaseForPrecisionMedicineInBreastCancer
Disease,non-hodgkinLymphoma
Other,retrospective
Other,inOfGamma-ggtTransformedIntoNir-sn-nh
Other,100000Person-years
Other,clinicalSetting
Other,frequentlyDetected
Other,cure
Other,incidenceFactorsOfSubsequentLung/bronchusPrimaries
Other,inLongTermHasFound
Other,generallyReserved
Other,identificationOfDistinctiveGeneticModificationsInDifferentBreastCancerMolecularSubtypes
Other,Differentiation
Other,Kiel
Other,intensive
Other,revisionsOfAjccBreastCancerStagingSystem
Other,repair
Other,proposedForBreastTumorGrading
Other,screeningTools
Other,cohort
Other,usefulness
Incorporation,studyObjective
Other,significantlyHigherPcrRatesThanPatientsWithLuminalTypes
Other,mixedMethodsDesign
Other,stageIiiBreastCaner
Other,survivalRatesOfLungCancerContinue
Other,244GermlinePathogenicVariants
Other,her2Expression
Other,ca15-3Detection
Other,QALY
Interval,note
Other,accurateMethod
Other,clinicians
Other,determinationOfUnderlyingBiologyWithinTumors
Document,detectionRateOfMutationsHigherThanThatDescribedInLiterature
Other,trials
Other,exon32OfMammalianTargetOfRapamycin
Other,unnecessaryRepeatBiopsies
Other,survivalRates
Other,tumorInformation
Other,per2Expression
Other,ourMethod
Other,diagnosisInMajorityOfInconclusiveCases
Provision,probablyTranscriptionalActivation
Other,cTn
Other,selectPatientPopulations
Other,27b
Other,howeverSignificant
Other,parameterUncertainty
Other,networks
Other,europeanCountries
Other,canDetectedInBodyFluidsIncludingSerum/plasmaSamples
Other,higherRisks
Other,acid
Other,couldSutegorizedIntoT2aWithCutoffValueOf3Cm
Other,necessity
Disease,FIT
Other,polymorphismOfFok1
Other,PM
Other,subsequentlyAssessed
Other,riskOfOtherLongTermAdverseHealthSequelae
Other,oneFamilyAffectedByCs
Other,PFS
Disease,gastricCancer
Other,breastCancerMcf-7
Provision,screeningBehavior
Other,drugExtravasation
Other,preclinicalPhase
Other,made
Other,35-64Years
Appearance,inConclusionDownregulatedInBreastCancer
Modulators,selectiveEstrogenReceptorModulators
Other,resistant
Other,humanPapillomavirusScreening
Other,twoPathways
Other,negative
Extract,highFreshLeafEthanolicExtractConcentrations
Other,trajectoryMembership
Other,genesInvolved
Other,bone-modulatingAgents
Other,haveUsed
Other,especiallyPost-neoadjuvantTreatment
Contraception,contraceptionUse
Other,medicalKnowledge
Other,bl1-subtypeTriple-negativeBreastCancer
Other,hsa-miRNA-143-3p
Other,standardizedDataCollection
Other,menopause
Cytology,mitochondrialMorphology
Other,histopathologicalExamination
Gene,RANKL
Other,breastCancerImagingSetting
Other,currentResults
Incorporation,followingStudy
Other,newOpportunitiesForDevelopmentOfNovelTherapeuticStrategies
Other,Promoting
Other,younger
Other,given
Other,scalable
Other,recognizingMethylationStatus
Other,Breast
Other,indispensable
Disease,malignancies
Neuropathy,irregularHyperintenseLesionInT2InLeftParietalRegion
Other,priorMedicalHistory
Other,244GermlineVariants
Other,5Îœl
Other,netherlandsCancerRegistryOf37230PatientsWithEarlyBreastCancer
Distance,first
Other,foxc1Function
Other,supportVectorMachine
Other,variousOtherCancerInHumanBody
Other,moreDirectional
Provision,localControl
Provision,breastCancerControlEffortsForIdentification
Other,cancerCounseling
Other,imagingFeatures
Other,roughly15000Cases
Other,respondents
Other,biologicalHeterogeneity
Resistance,physicalActivity
Disease,autoimmuneDiseases
Exposure,highestPerformance
Distance,density
Other,lesions
Other,needed
Other,uncouplingOfInverseCorrelationBetweenBmi
Neuropathy,lesion
Other,accessToEarlyDiagnosis
Other,tolerabilitytheApatinib
Other,aspirinTherapy
Other,particularlyPertinent
Other,non-ideal
Other,including
Extract,averageRisk
Other,significantAssociationBetweenRs5743810AllelicFrequency
Other,tumorSites
Granuloma,veryRareCaseOfTraumaticBreastNeuroma
Other,hundreds
Other,27PerCentOfPatients
Other,diagnosisOfBreastCancer
Other,proteinExpressionOfNf-krab-p65
Other,measures
Other,thoughtfulMultidisciplinaryPlanning
Other,nationwideRegistries
Other,overallMediumSecondTumor-freeTime
Other,threeCases
Other,exceedinglyRare
Mortality,mortalityRates
Other,threeDifferentUsMachines
Disease,tendinopathy
Other,features
Other,good
Other,significantIncrease
Other,120Patients
Other,recentEpigenomeStudies
Resistance,theirApplication
Provision,effectsOfAnnexinA3OnBreastCancerBiologicalBehaviorInVivo
Other,hasPutOnIntrinsicSubtypingBasedInPresenceOfClassicalImmunohistochemistry
Other,couldPotentialBiomarker
Images,mammographicImages
Other,noninvasiveImagingTechniqueForBreastCancerDiagnosis
Other,pooledUptake
Other,axillaryDissection
Other,10Countries
Other,familyHistoryOfDisease
Other,associationOfToll-likeReceptor6WithBreastCancerInSaudiArabianWomen
Gene,TP53
Other,2921Posts
Other,underlying
Other,designed
Other,significantlyHigherThanInFamiliesOfNfpaPatients
Other,desirable
Neuropathy,preventionOfChemotherapy-inducedNeuropathy
Other,forWomenWithBreastCancerMayMoreFeasible
Other,Japan
Other,Survival
Other,heterogeneity
Other,alongsideRoutineMethodEmployedOnTexture
Other,forRace/colorVariableEstimatedWithAdjustmentForStatus
Other,knockdown
Other,purpose
Other,77Patients
Other,vap-1ImmunohistochemicalStaining
Incorporation,incorporation
Other,propagation-basedPhase-contrast
Other,whenonlyAnalyzed
Other,longScanTime
Interval,medianLatencyTime
Other,stageIi
Other,saudiArabianWomen
Other,cancerPatients
Other,decreasesInMortalityRates
Extract,averageOfFiveInvolvedSites
Other,ukCancerIncidence
Other,complexConsulting
Other,stage
Disease,chestWallLesions
Other,appliedTo70PatientsWithUnilateralRl
Other,T2
Other,article
Disease,amenorrhea
Other,anthracyclineChemotherapyAgents
Other,thereforeCentralTarget
Relapse,greaterthanorequalto10PercecntDecline
Other,lymphedemaseventyPatients
Other,electricalDouble-layerCapacitors
Other,criticalRoles
Other,highVariability
Other,improvementInClassificationOfMalignantLesions
Disease,aromataseInhibitors
Other,tertiarySexualHealthCenters
Cytology,breastCancerGeneticsInKenya
Other,femaleSibling
Other,tumorSite
Other,otherSignificantConcerns
Other,inheritableBi-objectiveCombinatorialGeneticAlgorithm
Other,learning
Other,knowledgeSummaries
Gene,growthHormoneReceptor
Other,hybridChemicalProteomicsApproachTermedByEngineeringSrcHomology2
Food,rural-basedTertiaryCancerCareCenter
Other,pragmaticApproachToPopulation-basedCancerScreening
Other,C1
Other,couldSutegorized
Other,DOACs
Other,howeverLargelyUnreported
Other,poorerPrognosisInPatients
Other,prognosticFactorsOfCancerProgression
Other,deregulatedMirnas
Other,inception-v3Cnn
Other,sensitive
Other,BMI
Other,Screening
Other,Metastases
Other,contraceptiveUse
Sleep,age
Other,tackled
Other,q12X
Other,advancedAnalysis
Other,largestReviewOnPrsInAsianPopulation
Scoring,Scoring
Other,designedByDivisionForBreastCancerOfKoreanRadiationOncologyGroup
Carcinoma,Carcinoma
Resistance,physicalActivityInPatientsWithMetastaticBreastCancer
Other,effectiveness
Other,mostFrequentlyObserved
Appearance,betterDiagnosticAccuracyThanFfdm
Aptamer,aptamerMf3
Other,72Months
Other,This
Food,hotIssue
Other,matthewsCorrelationCoefficientOf8038Percecnt
Other,0-5Years
Other,components
Other,itsRole
Appearance,accuracyScores
Other,standardMethod
Almaty,howeverGreaterforPatientsTreatedInAlmatyCity
Other,trastuzumabInitiation
Other,We
Other,long-termEstimates
Disease,upperGastrointestinalCancers
Other,severalIntelligentTechniques
Disease,melanoma
Other,tumorGrowth
Other,26894People
Other,scrutinized
Resistance,cellInvasion
Modulators,associationBetweenUseOfSelectiveEstrogenReceptorModulators
Other,prognosisOfPatientsWithMaleBreastCancerInShanxiProvinceOfChinaFrom2007To2016
Document,limitedLiterature
Other,subtype-specificPrognosticSignatures
Other,twenty-twoPatients
Skin,significanceLevel
Disease,calvarialLesions
Other,unusualImmuneProfiles
Other,provedByExperimentalEvidence
Other,identifiedAsMostEffectiveMolecules
Other,proteinKinaseCInhibition
Other,inMarch2014BroadcastedAsPart
Resistance,potentAnticancerActivity
Other,40Percecnt
Collision,potentialImpact
Other,pregnancyOutcomes
Other,mostCommonNeoplasms
Other,commonPlatformForStakeholdersIncludingPolicymakers
Other,restoration
Other,SUM159PT
Food,coreNeedleBiopsy
Chemical,aspirin
Chemical,DDT
Other,traditionalPredictors
Other,youngMen
Other,mainMeasures
Other,cross-linked
Other,606Percecnt
Other,whenIntegratedWithinCountry/region'sHealthPlan
Other,advancesInBreastCancerDiagnosis
Microenvironment,imbalanceInCytokineProfilesInPro-tumorigenicMicroenvironment
Food,multiplexedAssayForDetectionOfAutoantibodiesInCanineTumours
Other,subsequentAxillaryLymphNodeDissection
Other,28Segments
Species,woman
Gene,Period2
Neuropathy,chemotherapy-inducedNeuropathy
Other,pi3k/aktSignaling
Other,trends
Resistance,anticoagulantChoice
Food,education
Other,brca-associatedCancers
Other,20
Mother,absorptionImagesAcquiredWithMonochromaticX-raysFromCompactSynchrotronSourceBasedOnInverseComptonScattering
Other,medianProgression-freeSurvival
Other,improvedQualityOfLife
Other,hypomethylationSites
Skin,mrnaExpressionLevelOfPcdh10
Document,model2
Other,medianOs
Appearance,caseRecords
Other,highestSe
Other,suspected
Skin,growthOfCancerCellsInSkinOriginatingFromInternalCancer
Food,furthermoreCouldDevelopedAsPotentialTherapeuticAgentAgainstMcf7-cell-related
Baseline,baselineSt-2Level
Other,multipleBiologicalRolesIncludingParticipationInImmunosuppressiveStudies
Other,costs
Other,picture
Other,smallMoleculeInhibitors
Other,similarlyInPancreaticCancersHaveSuggestedAsDiagnosticBiomarker
Analogs,their5h-pyridoPyrrolizin-5-oneAnalogs
Other,whenSevere
Other,anti-oncogenicRegulationOfMir-34s
Other,proxyForcvd
Disease,metastasis
Other,ourFindings
Other,taiwanLongitudinalHealthInsuranceDatabase2005
Other,immunohistochemicalAnalysis
Resistance,modestAnti-tumorActivity
Other,country
Other,undifferentiatedNeoplasticCells
Other,potentNon-secosteroidalVdrModulator
Disease,Metastasis
Other,lungCancerInHuman
Other,cancerSurvival
Consensus,consensus
Other,ruralSetting
Other,humanEpidermalGrowthFactorReceptor2ReceptorStatus
Other,furtherFound
Other,severalObjectives
Cytology,morphology
Other,confounders
Other,severalIndividuals
Other,femaleBreastCancerMortality
Other,biopsy
Other,evenSeveralChemotherapySessions
Other,survivalRate
Other,populations
Other,Radiotherapy
Other,historyOfBreast-conservingSurgery
Other,cytotoxic
Pathogenic,pathogenicVariants
Other,concentrations
Other,canDiagnosed
Other,evidenceForbenefits
Other,adultPatientsDiagnosed
Other,inexpensive
Other,resultCompatibleWithMetastasisToOrbit
Other,progressionOfSeveralTypesOfNeoplasms
Other,themselves
Other,summary
Other,broadUseToPatients
Disease,triple-negativeBreastCancers
Other,featureSelection
Other,inhibited
Other,nuclearFactors
Other,actualIncidence
Other,allCloselyAssociatedWithPttTherapeuticEfficacy
Endocrine,hormoneReceptor-positiveBreastCancer
Other,continuousRisk
Other,differentmethodsOfSelf-treatment
Other,targetedTherapies
Other,AUC
Other,CIAPIN1
Extracts,pseuderanthemumPalatiferumRadlkExtracts
Other,factor
Provision,evenMorePersonalizedFollow-upSchedules
Other,Ki67
Other,divergences
Other,itEffects
Incorporation,amongThemNewlyIdentifiedInStudy
Other,additionalAnalyses
Other,oneMutation
Other,theirParticularity
Other,invitedInputFromExpertsInSpecificAreas
Other,expressionLevels
Other,foxc1-knockdownBt549Cells
Regions,differentFunctionRegions
Other,dissection
Post-diagnosis,associationBetweenPost-diagnosisUseOfLow-doseAspirin
Other,osAdvantage
Infrared,secondaryConfirmationOfSignalAccumulationUsingNearInfraredFluorescentImaging
Other,humanBiofluid
Other,borders
Other,optimalCut-offValue
Other,obtainedFromPatientsWithBreastCancer
Other,has-miR-3158-3p
Other,medianTime
Other,bioactivity
Other,twoCases
Other,comparisonOfPredictedIncidenceOfBreastCancerWithActualIncidenceInPopulation-basedStudies
Other,correctionMethod
Lifestyle,diagnosisOfResponseToTreatment
Sarcomas,softTissueSarcomas
Other,Use
Other,variousMethods
Other,searched
Other,toxic
Disease,dyspareunia
Other,mostCommonUltrasonographicFindings
Other,evidence
Other,Zt/g4-MMAE
Other,hasWidelyUsed
Other,hasMade
Other,ourFacility
Other,Risk
Other,risingTrendOfColorectalCancers
Other,idiopathicGranulomatousMastitis
Other,mostTumors
Other,imagingFeaturesOfCommon
Other,intopreGroups
Other,Efforts
Other,mayUsedForTumourShrinkagePriorToSurgery
Other,Therapies
Other,multivariate
Other,mightPromisingTherapeuticStrategyForHormone-therapyRefractoryEr
Other,balb/cNudeMiceBearing
Other,mustAddressedDuringCancerGeneticCounselingConsultations
Exosomes,circulatingExosomes
Other,old
Other,mayDetected
Other,suchLowIncidence
Other,comparisons10-yearSurvival
Other,obtainedFromMedicalSpecialists
Other,reports
Other,strong
Other,signalAmplificationStrategies
Other,investigate
Other,especiallyPromising
Other,breastCancerInAdultsInChildren
Other,westernBlotting
Interval,excellentPerformanceInFieldOfMedicalImagesDiagnosis
Other,+239Percecnt
Other,earlyBiomarkersOfBreastCancerRisk
Other,approved
Other,tumor-bearingMiceOfMcf-7BreastCancerCells
Other,700
Document,associationBetweenNsaidsExposureInFemalePatientsWithAd
Interval,field
Other,occurringCancers
Other,breastCancer-specific10-yearSurvival
Other,ourBreastCancerPatients
Other,associationWithImagingOfIgm
Other,threeParadigmaticExamples
Cytology,surfaceMorphology
Other,hasValidatedDatabase
Other,731Percecnt
Other,elevenPatients
Other,january1998June2017
Other,effectsOfTreatment
Other,necessary
Interval,preliminaryGroupOfCtibl
Sleep,stratifyingForAge
Resistance,capacitance
Other,couldDetectedByMammographyBySelf-detection
Other,invasiveCarcinomaBreast
Appearance,inConclusionStillNecessaryForAdoptionOfCtnAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
Quantification,observation
Relapse,withBetterDrugDeliveryPotentialOfNon-sphericalShapesHaveRecentlyInvestigated
Other,patientsWithMAmongThem
Other,immunocytochemicalStudies
Other,women'sCancerAccounting
Other,evidence-basedDecision-makingForPopulation
Other,expressionOf6CirculatingMirnasInOperablePatients
Exposure,finiteSamplePerformanceOfProposedMethods
Extract,clearEvidenceForbenefitsOfTanUsageInBreastCancerClassification
Other,developmentOfBreastCancer
Other,activatedComplex
Other,aberrantlyExpressed
Other,complexSemisolidMasses
Relapse,betterOutcomes
Other,SD-CNN
Other,solidTumors
Other,survivalVariance
Other,shallowCnn
Other,brca1Wild-typeCells
Other,manyWomen
Other,imagingModalities
Other,unusualPresentationOfSuperiorVenaCavaSyndrome
Obstacle,obstruction
Other,bleedingRisk
Document,randomEffectsModel
Other,discrete-timePartiallyObservableMarkovDecisionProcess
Other,levels
Other,positiveForGata3In93PercecntIn78PercecntOfCases
Other,morcFamilyCw-typeZincFinger4Overexpression
Other,causal
Other,tangshanPeople
Other,oncoproteins/cancerSuppressors
Other,substantialSubsetOfTotalSample
Other,immunohistochemicalTests
Other,practitionersKnowledgeable
Other,G
Other,three6-monthPeriods
Other,potato
Food,potentialOfAionAsEffectiveMultimodalContrastAgentForBreastCancerDiagnosis
Other,22Deaths
Other,newFpReductionTechnique
Other,dominantArms
Dysplasia,regressionModels
Other,patientSelectionForNon-pcosReferenceCohort
Interval,observedInTransfectionGroup
Other,chemotherapy
Hyperglycemia,cell-killingEffect
Other,figures
Other,8155Patients
Lifestyle,objectiveResponseRate
Other,problem
Other,methylationStatusOfPcdh10InBreastCancerTissues
Other,133Controls
Other,featureFactorsOfPrss
Other,initialPresentationOfInvasiveBreastCancer
Other,twoTumorGroups
Other,advancedDiagnosticImaging
Other,third
Other,aggressiveManagement
Other,that
Other,effective
Other,falsePositives
Other,womenWithMore70PercecntOfPatientsTreatedWithHormonalTherapy
Other,programs
Sleep,ageOfTreatmentMethods
Other,increasedRiskWithUseOfLevonorgestrelIntrauterineSystem-bothOfPotentiallyImportantFindings
Other,prostateCancers
Other,faSignalingNetwork
Other,differentLevelsOfCk19
Other,56Patients
Other,predictors
Other,underway
Other,mortalityRate
Other,numberVariants
Disease,malignancy
Other,paTreatment
Neuropathy,possibilityOfEarlyDetectionOfRiskOfOsteoporosisToItsDevelopment
Other,colon
Other,positiveTreatment
Images,increasedContrast-to-noiseRatioForMonochromaticOverClinicalImagesForWell-definedPhantom
Other,furtherDevelopment
Other,promisingShort-termStrategiesPriorToTreatmentAdministration
Other,hdgcTestingCriteria
Other,OSs
Other,inclusions
Other,Steps
Other,neoadjuvantAnti-her2Treatment
Other,detectionOfMicrocalcificationInMammograms
Disease,lymphoma
Food,kernelApproach
Other,convolutionalNeuralNetworks
Disease,cancers
Other,colonyFormation
Other,featureMiningFromRois
Disease,pleuralMetastasis
Other,metabolicChanges
Other,etiologyOfManyDiseases
Other,evenNeeded
Other,furthermoreAssociated
Other,bloodSamples
Other,65Ng/mlForProgranulinFor-1
Neuropathy,generallyFibrosis
Other,antibodyDrugConjugates
Disease,tumours
Resistance,netvizzApplication
Sarcomas,forty-twoHigh-gradeSarcomas
Exposure,enlargement
Other,quality
Other,0.0001
Disease,AD
Other,involved
Other,knowledgeOfM
Other,RiskProtection
Other,imagingTechnique
Other,RFFS-GS
Other,typicalImagingPattern
Food,cancerCareCenter
Other,importantRole
Other,structureChanges
Other,methodsDesign
Autoantibodies,autoantibodies
Other,conditions
Other,drawbacks
Other,patientsWithLocoregionalInSouthernPortuguese
Other,contribution
Other,Irradiation
Other,established
Other,oncology
Other,improvedUnderstanding
Other,mda-mb-231CellsMeasuredBy3
Other,1973To2014
Other,preoperativeUnderstanding
Other,canEasilyExtended
Sleep,stillSeriousHealthProblemIn21stCenturySubjectToManyResearch
Other,mostlyBilateral
Other,tightDoctor-patientCollaboration
Other,38Months
Other,general
Sprays,ddtSprays
Document,threePapers
Chemical,vitaminD
Other,oestrogenReceptorCofactors
Other,shouldElaborated
Other,0.46
Other,clinico-pathologicalRiskFactors
Interference,assessment
Other,she
Other,prevention
Other,molecularAnalyses
NSAIDs,NSAIDs
Other,riskOfDevelopmentOfGliomas
Other,class
Gene,ESR1
Other,protocol
Gene,DESI-MSI
Other,systemicChemotherapy
Interval,latencyTime
Obstacle,obstacle
Other,hasAssociatedWithPoorCancerScreeningUptake
Interference,theory-basedIntervention
Other,opportunitiesForResearchInBreastSurgery
Other,childHealth
Other,treatment
Other,prognosisMoreAccurately
Chemical,omega3FattyAcids
Other,prognosticFactorIndependentOfOtherClinicalVariables
Other,lowCountries
Other,her2-positiveA
Surgeons,Surgeons
Other,add-onToConventionalUltrasoundEquipmentApplicable
Document,ourLiteratureReview
Other,theirSurvival
Guidelines,guidelines
Other,differentiallyExpressedInBreastCancerCells
Other,responsibleMechanisms
Other,resultsDiagnosed
Lifestyle,subtype-specificSignature
Other,conjugatedEquineEstrogen
Other,malignantProgressionOfBreastCancer
Skin,pax6OverexpressionIncreasingMmp2Andmmp9ExpressionAtMrnaLevel
Probe,handheldProbeCapable
Other,876PercecntRespectively
Mastectomies,mastectomies
Late-stage,risksOfLate-stageDiagnosis
Other,novelTherapeuticBiomarkerForDiagnosis
Other,lobularCarcinoma
Other,rightMastectomyWithSentinelLymphNodeBiopsy
Other,6Years
Other,17Years
Appearance,caseOf39-year-oldManPresentedToUsWithMultipleSuutaneousLesionsOverChest
Other,strongContrastWithImagingModalities
Other,autosomal-dominantlyInheritedCancerSyndromeAssociatedWithRiskCausedByHeterozygousCdh1GermlineMutations
Other,lipidProfiles
Troponins,troponins
Probe,intravenousAdministrationOfOsteopontin-750Probe
Macroadenomas,macroadenomas
Similarities,similarities
Provision,pathologyForFurtherFollow-up
Markers,estrogen-receptorAmongOtherMarkers
Other,added
Other,clinico-epidemiologicalFeaturesOfBreastCancer
Other,ourTheoreticalAnalysis
Other,DAU
Other,lowIncidence
Granuloma,Granuloma
Other,They
Other,suchStandardization
Other,familyHistory
Other,tool
Other,hazardsOfBleeding
Other,18.791
Other,variability
Other,19
Other,researchDevelopment
Gene,SOX9
Other,incidenceFactors
Other,Kazakhstan
Other,clinicalFeatures
Other,insight
Other,LMICs
Other,mostFrequentMetastaticTumors
Disruption,disruption
Other,parpInhibitors
Other,womenAcrossGlobe
Other,patients'Self-monitoring
Other,mainlyEurope
Other,highlyPenetrantGenes
Other,molecularDiagnosisMethodMake
MSOT,MSOT
Other,aspect
Polymorphisms,occurrenceOfPolymorphisms
Other,negativelyCorrelatedWithLvef
Other,molecular
Other,interplay
Disease,metastasize
Other,childbearingReasonsIncluding
Other,observationalStudies
Other,whenPerformedBeforeMenopause
Other,studied
Other,neurocognitiveSequelae
Appearance,differenceBetweenDifferentBreastCancerSubtypes
Other,abbreviatedMriProtocols
Other,age-matchedSystematicRandom-samplingMethod
Other,pattern
Other,mir-193b-3pBindingTo3UntranslatedRegionOfMorc4
Other,Change
Other,rate
Other,detectionOfBreastCancerInWomen
Other,CK
Other,breastCancerTissueMicroarrayWithAccessToReceptorAnalyses
Other,asianCountries
Disease,Hyperprolactinemia
Other,couldDetectedEarly
Other,itsExpression
Other,5CmLess
Other,tomography
Collision,theyCanImpactOnQualityOfLifePresent
Other,typical
Other,pfh-ptx@plgaSpio-her
Other,significantEnrichmentOfCdh1MutationsWithinEcDomainsInComparisonToCdh1MutationsAssociatedWithHdgc
Other,complex
Other,specialEmphasisOnTheirDifferentialDiagnosis
Other,cancerTreatment
Endocrine,imagingOfProstate
Inhibition,Inhibition
Skin,alarmingLevelGlobally
Other,dcisDiagnosis
Other,developmentOfSubsequentLung/bronchusCancer
Distance,haveReportedForFirstTimeInCaninesInStudy
Other,ELISA
Other,asymptoticPropertiesOfEstimatesCalculatedFrom
Other,doseConcerns
Distance,firstYearsAfterWithdrawal
Other,potentialMechanismForFoxc1-inducedMetastasis
Mammographic,Mammographic
Disease,dysplasia
Post-diagnosis,associationBetweenPost-diagnosisLow-doseAspirinUse
Other,neuralNetworkClassifier
Other,bilateral
Other,levelsOfEralphaProtein
Other,epigeneticChanges
Other,consequentlyPredicted
Other,significantChallenge
Other,MultipleMyeloma
Other,tumorNeoangiogenesisSimilarToBreastMagneticResonanceImaging
Other,strongAssociationBetweenRs5743810AgainstRiskInSaudiArabianWomen
Gene,PALB2
Other,additionallyRevealed
Other,oncogenesEsr1
Other,burdenOfCervicalCancer
Other,understudied
Other,otherTwoGroups
Other,approximated
Other,review
Other,novelInsightsIntoPotentialMechanismsAssociatedWithBreastCancerPathogenesis
Other,resultOfPresentationWithAbnormalUterineBleeding
Other,Univariate
Other,advantages
Other,specimen
Relapse,betterResults
Other,diverse
Other,predicted
Sequencing,sequencing
Other,simulatedInnerBreastTissue
Other,studiesFocused
Other,dysregulation
Other,handicap
Other,thusPresented
Interval,interval
Drugs,developmentOfNewDrugs
Complexes,phosphotyrosineRegulatedProteinComplexes
Autoantibodies,roleOfAutoantibodiesInEarlyCancerDiagnosis
Other,replaced
Other,hasFound
Other,incision
Other,skullLesions
Other,Angiogenesis
Disease,neoplasms
Other,11HereditaryBreastCancerGenes
Other,poorPrognosis
Other,hasAssociated
Other,NCCN
Other,widespreadInterest
Other,technique
Other,putativeBiomarkerForDetectionOfVariousHumanDiseases
Other,patientsWithNeoplasticDisease
Disease,breastCancer
Other,x-rayMammography
Other,actSynergisticallyWithPaclitaxel
Other,caloricRestriction
Other,erEvaluation
Other,value
Other,hoechstStaining
Other,modified
Document,nudeMouseModel
Other,481Women
Sleep,significantlyYoungerAge
Other,areUsed
Hyperglycemia,novelStrategiesForDiagnosisOfBreastCancerWithHyperglycemia
Other,anti-her2Therapy
Other,876Percecnt
Extract,mostImportantCause
Other,patientsWithHistoryOfBreastSurgery
Other,currentlyInsufficient
Other,motivated
Disease,cleftLip/palate
Other,mostEffectiveTechniqueused
Other,target
Other,finding
Probe,nirProbeNir-sn-ggt
Disease,nausea
Other,comprehensiveResearchData
Other,c1711
Disease,infertility
Other,radiation
Document,modelAccount
Other,57PercecntOfPatients
Neuromas,only35CasesOfTraumaticBreastNeuromas
Other,breastCancerScreening
Other,eralphaTranscription
Other,mammograms
Disease,collisionTumor
Other,10Percecnt
Other,howeverWidelyUnderstood
Document,improvedDiagnosticContentOverEx-vivoClinicalMammographyImagesAtLowerDose
Other,vap-1Expression
Other,stagingSystems
Other,microRNA
Other,detectionofBreastCancer
Other,explored
Other,Barshi
Other,FFDM
Other,1
Other,beta-SDG
Other,lower
Other,alreadyWell-established
Post-diagnosis,time-varyingPost-diagnosisLow-doseAspirinUse
Resistance,choiceOfChemotherapyInBrca-associatedCancers
Other,different
Other,opportunities
Other,obtainedFeatures
Other,continuousPattern
Food,impairedBaselineCardiacFunctionExperience
Other,higherRatesOfMisdiagnosisForBreastCancer
Dysplasia,penalizedLogisticRegression
Other,haveClarified
Areola,haveAssociatedWithNippleAreolaComplexInvolvementInPatientsWithBreastCancer
Other,adenocarcinomaFeatures
Other,14644Patients
Other,oneRegionAnother
Interval,intervalBetweenDiagnosis
Other,asianPopulation
Appearance,inNumericalSimulationsAccuratelyReconstructedWith90PercecntAccuracyUpToNoiseLevelOf50Percecnt
Other,clinicalDepression
Provision,directActingOralAnticoagulants
Other,cancerTherapy
Other,monteCarloFeatureSelection-basedFeatureSelection-basedComputationalMethod
Other,reverseTranscription-quantitativePolymeraseChainReaction
Gene,SMARCAD1
Other,asymptomaticWomen
Other,Japanese
Other,fluorescenceImagingExVivo
Extract,mostFrequentCause
Other,defined
Other,adPatients
Other,Prevalence
Other,available
Other,advancedBreastCancerTreatment
Other,longNoncodingRnas
Other,shown
Other,informationNeeds
Other,cytotoxicActivitiesOnMcf7
Other,whereFacilitatedBySurfaceModificationOfNps
Provision,activation
Disease,polycysticOvarySyndrome
Other,smallProportion
Other,youngWomenWithInvasiveLobularCarcinoma
Other,25-year-oldWoman
Other,largestCancerPatientCohortStudies
Distance,itsFirstDescription
Other,maintenanceOfErCancerStemCells
Other,investigatedOnly
Other,lessBleeding
Other,dynamicContrast
Other,induction
Other,kmt2aFusionGenes
Other,experiences
Disease,inflammatoryTumour
Transmembrane,mitochondrialTransmembranePotential
Other,breastReconstruction
Other,acceleratedPartialBreastIrradiation
Appearance,surgicalAccuracy
Plasticity,univariateSensitivityAnalysesresults
Other,associationsWithDiseasesLikeTypeI
Other,certainCancers
Document,similarToThatReportedInLiterature
Sleep,medianDiagnosisAge
Other,lapatinibCombined
Other,adults
Other,theirContraceptivePreferences
Other,expressionOfMir-511InBreastCancer
Other,biocompatiblePfh-ptx@plga
Chemical,Tamoxifen
Other,the
Other,diagnosisOfPatientsWithBreastCancer
Other,7Percecnt
Resistance,moreImportantlyCanNowComplementedByEmergingDeepLearningTechniquesForFurtherProcessAutomation
Other,potentialTherapeuticTarget
Other,inhibition
Other,miRNA
Other,robust
Other,care
Other,952PercecntOfthePostmenopausalWomen
Other,brd4PharmacologicalInhibition
Other,areInvestigated
Other,recentlyDevelopedBreastImagingTechnique
Other,costOfMriExamination
Disease,superiorVenaCavaSyndrome
Users,12331Non-nsaidUsers
Other,widerPopulationOfPatients
Other,association
Other,analysed
Disease,carcinogenesis
Skin,needForAwarenessOfMimicsOfBoneMetastasis
Distance,date
Disease,obesity
Disturbances,sleepDisturbances
Other,thusCritical
Other,method
Other,haveCenterstage
Other,receptorTyrosineKinasePdgfrb
Species,human
Other,objective
Other,252Percecnt
Other,transport
Other,strategies
Other,sw-22
Other,multipleBiological
Other,neoadjuvantTreatment
Other,gender
Resistance,Cell
Other,therapy
Other,breastScreening
Other,january1990
Other,hospitalizations
Other,estrogenReceptorBeta
Other,cnvsOfDifferentCancers
Other,patientsWithBreastCancer
Other,lowClassificationAccuracies
Craniotomy,incompleteExcisionOfMalignantTissues
Other,lentivirusTransduction
Other,hsa_circRNA_102101
Other,limitations
Other,Acupuncture
Other,majorAdvance
Other,89Participants
Other,treatmentOutcomePrediction
Other,breastBiopsies
Other,cutaneousMetastasis
Other,differentGeneticProfile
Resistance,application
Other,Cells
Interval,correspondingHistologyImage
Other,CTCs
Other,Epidemiology
Other,spectrum
Other,availableContrastAgents
Other,willLeadToMortalityReductionsWithoutUsualScreeningHarms
Other,directEffects
Other,threeKinds
Other,output
Other,62Years
Other,sample
Other,pharmacokineticParameters
Other,thatOfOtherCountries
Other,carbohydrateRestriction
Distance,firstDose
Other,otherData
Other,multiresolutionResult
Interval,keyHypomethylationSites
Other,alternativeOption
Markers,markersOfMesothelioma
Interference,scalableIntervention
Other,microRNAs
Other,largelyConsistent
Other,roleOfCircularRnas
Other,greatProgress
Other,subsequentRadiomics
Other,bilateralBreastLumps
Other,99PercecntOfCases
Infrared,mildUvLight
Other,upregulated
Other,limited-angleFourier-domainSosReconstruction
Other,eventHybridizationOfMirna-21Biomarker
Other,9h-pyridoPyrrolizin-9-one
Other,inclined
Behaviours,theirHealthBehaviours
Other,solubleMediators
Other,sensor
Other,areaOfResidence
Appearance,goodDiagnosticAbility
Other,manyBreastCancerPatients
Provision,breastCancerControlEfforts
Endocrine,humanChorionicGonadotropin
Other,promoterMethylationInCertainTypesOfHumanTumors
Species,patients
Other,distinctiveGeneticModifications
Other,unknown
Other,increasedRiskOfEndometrialCancer
Other,sparseCoding
Other,sometimesMistaken
Sleep,ageGroups
Polymorphisms,resultsOfIndividualVdrPolymorphisms
Other,moreoverSignificantlyLower
Exposure,itsDiagnosticPerformance
Other,existence
Other,inverselyCorrelated
Other,surfaceArea
Other,proteinLossOfPtenByPhosphorylation
Other,poor
Other,expectedInverseCorrelationOfSerumDdtsWithBmi
Other,haveAllProposedAmongPotentialPathways
Interval,imageSegmentation
Other,itsRelativeClinicalSignificance
Other,recurrentHyperprolactinemia
Other,improvedPatientOutcomes
Other,long-termUse
Other,similarPfs
Other,femaleNudeMice
Gene,ERBB2
Other,conclusionsWomen
Other,properAccessToDiagnosis
Applicability,applicability
Other,occurrenceOfBreastCarcinoma
Appearance,defectStudies
Interference,finalAssessment
Other,excision/lumpectomy
Other,recommendations
Other,breastCancerTissue
Other,prospectivelyFollowedFor3YearsSinceDiagnosis
Other,breastConservation
Craniotomy,surgicalExcisionWithRadiation
Other,clinicopathologicalFeaturesOfT-mnPatients
Other,apoptosis
Other,obtainedFrom66FemalePatientsWithMAtDifferentTimeIntervalsForEvaluationOfCtcsByFlowCytometry
Other,back-splicingMechanism
Other,registered
Food,patientEducationIdentification/reportingOfSideEffects
Other,specificityImprovement
Other,physician
Other,MetastaticLesions
Sequencing,therapeuticSequencing
Other,classic
Other,HeLa
Other,NMA
Other,hasObserved
Incorporation,study'sObjectives
Other,potentialForOverdiagnosis
Other,pathogenesisOfBreastCancer
Other,fewPercentOfWomen
Other,mayUsed
Other,49CedmCasesCollectedFromMayoClinic
Interval,keyRole
Plasticity,bodyMassIndex
Disease,colorectalCancer
Other,claimsDatabase
Other,example
Other,twoYears
Gene,p27
Other,nano-genosensor
Other,implemented
Other,rateIncrease
Other,subtype
Other,body
Chemical,anastrozole
Other,outcomesOfEstrogenReceptorPositive
Other,deepLearning
Other,promisingNon-invasiveReal-timeSurrogatesForCancerDiagnosis
Other,0.84
Provision,littleHelp
Other,thenUsed
Other,METHODS
Granuloma,EosinophilicGranuloma
Other,contrast
Other,proteinKinaseC/extracellularSignal-regulatedKinasePathwayInSpinalCordInLumbarSegments4-6
Other,haveProducedInLaboratories
Other,inTotalMatchedToCasesOnBirthYear
Other,adenosine-inducedScEnrichment
Other,noninvasive
Other,1YearTo5Years
Nanoplatform,theranosticNanoplatform
Issues,changesToIntimateIssuesIncludingSexualHealth
Other,t-MN
Other,positiveFeedbackLoop
Other,neutrophil-to-lymphocyteRatio
Other,thereforeCriticalSignificance
Appearance,percentageChangeInIncidenceRates
Other,resonanceImaging
Other,Anthracyclines
Other,needsInPrevention
Other,asResultAreUsed
Other,accomplished
Other,54BreastCancerPatients
Other,epidemiologicalFeatures
Resistance,course
Other,circulatingBiomarkers
Other,singleMetastaticSite
Other,test
Provision,moreIntensiveFollow-up
Other,significantlyAssociatedWithSeveralHealthOutcomesForTargetChild6YearsLaterIncludingCertainInfections
Other,adult1-yearCancerSurvivors
Other,gaslessRobot-assistedNipple-sparingMastectomy
Other,parameters
Chemical,warfarin
Other,expectedInverseCorrelation
Other,utilized
Other,depicted
Other,adverseEffectsOfMtorInhibitors
Food,foodRecommendations
Other,underutilized
Obstacle,collectionOfSignsResultingFromObstructionOfSuperiorVenaCavaIncludingSwellingOfUpperBodyOfHead
Document,copyright
Other,localTherapyOfBreastCancer
Other,guidePatients
Other,mustAddressed
Other,shallow-CNN
Interval,medianLatencyPeriod
Sleep,secondDecadeAfterDiagnosis
Other,shift
Other,tumorSamples
Cytology,invasiveLobularHistology
Other,thenShouldTestedForSpecificGeneMutationFound
Other,5T-mds/mpn
Other,detected
Other,yearRfsrate
Other,Symptoms
Other,mutationEvents
Resistance,aggressiveCourseOfHer2Cancer
Other,everolimus-exemestaneCombination
Species,women
Other,common
Interference,drugDeliveryStrategies
Other,1444Women
Other,targetVolume
Other,properties
Interval,periodFromApril2012ToDecember2017
Plasticity,massInPosteriorFossaOfBrain
Other,mapped
Other,aspirinUse
Other,decreasedRiskOfBreastCancerInFemaleAdPatients
Other,correlationCoefficient
Disease,advancedBreastCancer
Baseline,reducedBaselineCardiacFunction
Species,People
Other,top10InformationalNeedContents
Other,7PercecntForCdx2
Other,mir-10aExpression
Other,progressionOfTumorInvasionInBreastCarcinoma
Disease,carcinoma
Other,substantialDelayFromDiagnosisToTreatment
HER-2,caseOfWomanOnNeratinibForHer-2PositiveInfiltratingDuctalCarcinoma
Other,treatmentWithWholeBrainRadiotherapy
Interval,medianFollow-upPeriod
Other,haveSuggested
Other,wordCloud
Other,positivelyCorrelated
Other,selected
Other,malePatients
Resistance,activityOfTransplantedTumors
Other,predominant
Other,theirCare
Other,tumourSpread
Other,multiplexPlatform
Other,others
Exposure,goodDiagnosticPerformance
Gene,BRCA1/2
Hyperglycemia,effectOfDdtSpraysOnBreastCancerIncidenceRate
Probe,oxidativeStressProbe
Other,willTested
Other,expressionOfChemokineReceptor-4
Incorporation,cross-sectionalStudy
Other,tissueBiopsy
Other,standardOfCareAsFirst-lineTreatmentOfPatientsWithHer2-positiveAEvenInReal-worldSetting
Other,monteCarloFeatureFeatureMethod
Other,determine
Other,cancerResearch
Interval,state-of-the-artImageAnalysisMethods
Other,brcanessPhenotype
Other,Recurrences
Other,routineUse
Other,couldDetected
Other,referenceForClinicians
Disease,heterogeneousDisease
Other,subsequentPrimaries
Other,bivariateAssociations
Incorporation,inStudyFusedWithMouseMyelomaCellLineSp2/0InPresence
Other,youngMalePatients
Other,increasedDifferentiation
Other,circulatingSolubleRankl
Other,theirInteractions
Other,tools
Other,713Percecnt
Other,powerfulToolForEarlyDetection
Other,feasible
Other,canCategorized
Other,strategy
Disease,fanconiAnemia
Other,these
Other,elderlyPatientWithRelapsedHer2
Other,greaterthanorequalto1Lineage
Appearance,conclusion
Skin,contextOfTwoCasesOfBladder
Exposure,hemorrhagicEnlargement30YearsAfter
Other,4Domains
Other,pi3k/aktKinasePathway
Skin,st-2Level
Other,mostCommonOnes
Other,expressions
Other,conducted
Other,recurrenceRates
Other,thusPotentialTherapeuticTarget
Other,microfluidicPlatform
Other,muchFocus
Other,prospectiveStudies
Other,cancerManagement
Other,tumorGroups
Other,neutralEffects
Resistance,suppressionOfCellSurvival
Other,histopathologicDistinction
Other,one-thirdCases
Other,earlyStage
Granuloma,traumaticNeuroma
Chemical,estrogen
Other,pharmacokineticProperties
Other,overexpressed
Other,pik3caMutations
Other,womenWithG
Disease,AION
Other,ivimParameters
Other,featureSubsets
Disease,tumor
Other,effectivenessOfDifferentNpatsOnQolInPatientsWithBreastCancer
Other,howeverMaySometimesDifficult
Complexes,dynamicSh2ProteinComplexes
Other,techniques
Other,highVolumeAcademicCenters
Other,racialDisparity
Other,cancerSusceptibilityGenes
Incorporation,ronInternalization
Other,radiomicsScore
Other,mostPretermBirth
Other,loss
Other,CEDM
Other,breastCancerClassification
Other,phosphorylation
Other,primaryPurposeOfPeriodicMammogramsInScreeningProgramsIs
Other,Cases
Other,rates
Other,dual-luciferaseReporterAssays
Other,definition
Incorporation,case-controlAssociationStudyForVariantsInCodingRegionsOf11HereditaryBreastCancerGenesIn7051UnselectedBreastCancerPatientsOfJapaneseAncestry
Other,haveReported
Other,pD1542yMissenseMutation
Other,future
Other,estimates
Other,understood
Other,whenGiven
Other,screened
Other,danger
Other,pax6Overexpression
DNA,involvedInDnaDamageRegulation
Other,downregulated
Other,maintenance
Other,microrna-22ExpressionLevels
Other,18f-fluoro-deoxy-glucoseCombined
Appearance,643PercecntWithSignificantDifferenceBetweenWhites
Other,riskOfBreastCancer
Stigmatization,mostStigmatization
Other,patientsWithMeasurementErrors
Incorporation,includedInStudy
Other,medicalHistory
Other,formed
Neuropathy,adhesionProtein-1
Other,otherInotherTertiaryCentres
Other,significant
Other,breastCancerPatients
Other,aberrantExpression
Other,present
Other,presenceOfTendinopathy
Other,survivalThanAdjuvantTherapy
Other,canClassified
Other,typicallyBilateral
Other,sufferingFromWoman'sDisease
Other,ratio
Other,howeverHaveClarified
Other,familySupport
Other,0.00001
Disease,paraneoplasticNeurologicSyndromes
Other,delaysinTreatment
Other,shouldAnalyzed
Other,benignBreastLesions
Other,gynaecologicalMetastases
Other,theirInhibition
Other,breastCancerSubtypesa
Other,reductionOfFpsFrom085002Fp/imageForMias
Other,MP
Regions,sixteenRegionsOfKazakhstan
Other,her2Overexpressing
Other,scEnrichment
Lifestyle,influenceOfLifestyleFactorsOnPrognosis
Other,highMortalityRateForFemales
Other,indicated
Other,cervical
Other,recentlyDiagnosedBreastCancer
Other,formedByCo-encapsulationOfNear-infraredFluorophoreInPegylatedMicelles
Other,patterns
Other,c.
Other,initiationOfBreastMalignancy
Other,substantialRacial/ethnicDisparity
Other,commonFeature
Other,urgentClinicalProblem
Other,pathogenicVariantsInBrca1/2
Other,improvedCancerTreatment
Other,inspection
Document,model
Other,avoidance
Other,itsImportantRoleInEtiologyOfManyDiseases
Other,mostToxic
Other,Uncertainties
Other,included
Other,breastCancerTherapy
Other,likely
Other,addition
Other,inPaperUsed
Other,breastCancerCells
Other,usd$901
Other,aggressive
Other,whenSuspected
Other,moreAdvancedStages
Other,992Percecnt
Other,appropriateIntegrationOfPreprocessing
Other,report
Other,proliferation
Disease,neuropathicPain
Other,appropriateDiagnosisOfBreastCancer
Other,thepresence
Other,nsclcSamples
Other,essentialsRisk
Other,riskFactorForLung/bronchusCancer
Food,cellCultureSupernatants
Other,radicalSurgicalApproaches
Hyperglycemia,cell-killingEffectInTriple-negativeSubtypeMda-mb-231Cells
Other,68Percecnt
Provision,criticalScientificBase
Other,ruralCancerHospital
Other,complexDueToPotentialFoetalRisksInSettingOfMaternalTreatment
Disease,Prolactinomas
Other,shouldCo-managedByCardiologist
Other,manyResearchers
Other,abnormalUterineBleeding
Other,severe
Disease,GDM
Other,worseOsThanT2aSutegory
Other,30TBreastMagneticResonanceImagingExaminations
Appearance,change
Other,fiveDosesOfAdjuvantTranstuzumab
Interval,fieldOfCancerClassification
Other,26
Other,whereFormulated
Disease,Hypoxia
Other,505Percecnt
Other,allBreastCancerPatients
Other,dictionaryLearning
Other,twoSutegories
Disease,hereditaryDiffuseGastricCancer
Other,involvementOfPtenInCs
Food,differentContrastAgent
Other,canOnlyDiagnosedOnPresentationOfSymptoms
Document,papers
Other,hematoxylin
Other,inPreprocessingHasAchieved
Other,know-howWe
Other,Chi
Neuropathy,patientsWithHistoryOfTranstuzumab-inducedCardiacDysfunction
Interval,key
Other,vdrExpression
Pediatric,accurateDiagnosisInPediatricPatients
Interval,period
Interference,newerDrugDeliveryStrategies
Other,breastExamination
Other,mostRelevantKind
Other,disease
Other,moreoverMostOfTimeBenignRequired
Other,willTestedThroughEuropeanMyPersonalBreastScreening
Disease,primaryBreastDiffuseLargeB-cellLymphoma
Other,dual-energyAcquisition
Other,progression-freeSurvival
Other,cross-sectionalStudies
Other,successfullyUsed
Other,differentiallyExpressedCircularRnasInNeurologicalDisorders
Other,occurring
Other,venaCavaSyndrome
Other,advancedStage
Other,whereNeeded
Other,markerBands
Other,information
Other,fusionProteinsWithHaloTag
Other,ctnLevels
Other,canClassifiedAsSoluble-proteinBasedImmunocytochemical
Extract,complementaryBenefit
Other,adverseEventsExceptDegreeI-iiBleeding
Other,improved
Disease,metastaticBreastCancer
Other,leucocytes
Other,evaluation
Provision,controlTrial
Other,30DoublingTimesNecessary
Other,womenWithExtremelyDenseBreasts
Other,multiyearCollaborationLedByUnionForInternationalCancerControl
Images,opticalCoherenceTomographyImages
Other,t2Category
Resistance,mitochondrialTransmembranePotential-drivenRegulatedCellDeaths
Other,overexpression
Other,access
Capillaries,bareCapillaries
Other,xenograftMice
Other,personalDecision-making
Stigmatization,sexualStigmatizationOfM
Other,inflammatoryDiseases
Other,scope
Drugs,cardiotoxicityOfHer2-targetedDrugs
Other,efficientlySynthesized
Other,propensityScoreMatchingAnalysis
Other,20-year-oldWoman
Other,luminalB-likePatients
Other,tumorSuppressorGene
Exosomes,tumorInterstitialFluidDerivedExosomes
Other,Factors
Other,pax6GeneExpression
Other,developed
Resistance,transcriptionalActivityOfHypoxia-inducibleFactor1
Other,l-3Knockdown
Other,h&eStaining
Endocrine,amongOlderAdultsObservedForBreastCancerInFemalesForProstateCancerInMales
Other,mmp2Genes
Other,Analysis
Mother,conflictBetweenCareOfMother
Interval,group
Interference,preoperativeAssessment
Other,disrupted
Interval,latencyPeriod
Disease,her-2PositiveBreastCancer
Other,due
Other,primaryCareProvider
Other,90PercecntOfPatientsWithRecurrence
Other,resistantToExonuclease-mediatedDegradation
Other,healthySubjects
Other,longerPfs
Other,408
Food,experience
Other,independentReviewers
Other,antigenIdentification
Appearance,case
Other,anti-ronMonoclonalAntibodyZt/g4-drugMonomethylAuristatinEConjugate
Other,cancerRiskPerception
Other,sox9NucleusEntry
Nanoplatform,skeletonOfNanoplatform
Resistance,cancer-relatedEventsIncludingTumorCellMigration
Other,history
Other,targetedTumorAccumulation
Relapse,relapse
Other,clinicalCare
Other,hormone-dependentPositiveBreastCancer
Other,formulationOfEffectiveManagementPlanForAt-riskWomen
Other,manyFeatures
Other,3Malignancies
Other,417Percecnt
Other,hasReduced
Other,patientsWithCancer
Other,earlyBreastCancerDiagnosisOfBreastCancerRisk
Other,itsRelevantLimitations
Other,evenAdjustedForKnownPrognosticFactors
Other,Overexpression
Other,prognosticSignificanceOfNlrInEarlyStage
Other,webOfSciencePsycinfo
Disease,pretermBirth
Disease,CS
Other,4
Other,description
Sleep,otherAgeGroups
Other,hasRecentlyProposedAsCrucialRegulator
Other,vulnerability
Other,mostPrevalentType
Other,howeverUnderutilized
Other,relativelyGoodPrognosisWith5YearOverallSurvivalOf88Percecnt
Other,criticalImplicationsForTherapeuticDecision-makingInUrothelialCancer
Other,yetUnclear
Lifestyle,response
Other,alsoAssessedByQrt-pcr
Other,bl1-subtype
Other,hypothesis
Distance,firstSymptom
Other,advancedTechnologies
Other,risks
Other,healthyWaysOfLife
Resistance,characteristicsLikeCapacityForInvasion
Other,fundamental
Other,virtualReality
Provision,hasReducedThroughoutLastDecades
Other,benign
Other,potentialTreatmentStrategyForEndocrine-resistantBreastCancers
Other,reportedInSignificantlyHigherProportionOfPatientsWithPa
Other,applied
Other,employed
Other,majority
Other,novelMethod
Other,importantInsightsIntoDiagnosisOfPatientsWithDisease
Other,used
Disease,breastCarcinomas
Other,correlated
Other,aberrantExpressionOfBIn21PercecntRespectively
Other,contrastAfterInjection
Other,antibody-basedStrategy
Provision,2-groupRandomizedControlTrial
Disease,erythema
Other,haveIntroduced
Other,twoMoieties
Other,73-yearOldWomanPresentingWithLeftBreastLumpClinicallyIndeterminate
Incorporation,inStudyDevelopedForHighlyEfficientIsolationOfCtcsFromBreastCancerPatients
Other,percent
Other,persistentPain
Other,additionalInformation
Other,localEntropyMaximizationAlgorithm
Other,oralBeta-sdgAdministration
Other,detection
Other,screeningPrograms
Other,diagnoses
Other,decreases
Other,Transcripts
Other,adherence
Other,successfulFunctionalizationOfNanocompositeOfSpecificSequenceOfAminatedComplementaryOligonucleotideOfMirna-21
Other,combinationsOfInductionInBrca1Wild-typeTripleNegativeBreastCancer
Other,modificationPathways
Other,pax8AMetastasesOfCancer
Other,morc4Silencing
Other,twoChlorambucilPlatinum
Other,255Months
Other,patientsFrom10Countries
Other,clinicalBreastExaminationCoupledAsPrimaryTool
Other,5-Fluorouraci
Other,prevalent
Appearance,importanceOfNondestructiveTestingInDefectStudies
Other,needs
Other,evidence-basedRecommendations
Resistance,tediousCountingCell
Other,polymeraseChainReaction
Other,overallCumulativeRiskOfProgression
Other,mostCommonAgentsUsedInBreastCancerTreatment
Other,CGI
Other,shouldPerformed
Other,potentialReduction
Other,risksOfCancerInMutationsCarriers
Other,identificationOfPredictiveBiomarkersForSelectionOfOptimalTreatment
Other,outcomesAmongKoreanPatients
Other,currentAnalysis
Provision,unnecessaryFollow-upVisitsForWomenWithVeryLowRisks
Other,BRCAs
Other,fission
Other,heterogeneous
Other,circRNAs
Other,MCC
Other,differentiation
Other,drugBinding
Other,negativeEffects
Other,5-khzFrequencies
Other,1000Patients
Other,component
Other,immediateReconstruction
Other,mostPervasiveTypeOfCancerAmongWomen
Other,clinicalVariablesAmongDifferentGroups
Other,mightUseful
Other,denosumabInjection
Other,remodeled
Other,standard
Cytology,needleAspirationCytology
Interference,evenLessFrequentComplication
Other,planning
Other,survivalPrediction
Other,metastasectomy
Other,linkage
Other,riskFactors
Other,crucialRole
Other,staining
Other,littleSurvivalVariance
Appearance,interestingClassOfCompoundsWithVariedDegreesOfStructuralComplexity
Other,mostOfPatientsDuringMammography
Other,scan
Ethanolic,freshLeafEthanolicExtract-treatedMda-mb-231Cells
Other,unnecessarySubsequentExaminations
Other,theirCardiotoxicities
Other,mainlyPostmenopausalWomen
Other,retrospectiveReview
Other,inBelgiumMostFrequentWomen'sCancerAccountingForTo353PercecntOfCases
Resistance,panelOfCellLinesWithDifferentPhenotypes
Other,histologicalStructureOfTumorTissues
Other,PFH-PTX@PLGA
Gene,NCAM1
Other,highPercentageOfRemissionMaintenance
Other,aiDiscontinuation
Other,moreInformationAboutFurtherStratificationOfBreastCancerSubtypes
Other,patientsByTrastuzumab-pretreatment
Other,detectionRate
Other,matchedHealthyTissues
Other,effectsOfPcosOnRisksOfGynecologicCancer
Incorporation,inPresentStudyPerformedFor9Features
Other,conclusionsInPractice-basedSampleOfCa-vtePatientsAssociatedWithSimilarBleedingRisksToWarfarin
Other,hasAchieved
Disease,lungCancers
Other,familyMembers
Disease,cyanosis
Other,surgeon
Interval,tumorNippleDistance
Other,Lesions
Other,thereforeVeryPromisingStrategy
Other,segmentationAlgorithm
Dysplasia,regression
Other,dose
Other,M
Other,comparingWithCurrentStandardMethodOfSubjectiveVisualEstimation
Other,unitedStates
Other,greatestImportance
Markers,theirRelatedMarkersAtDifferentPointsOfChemotherapyRegimensInMetastaticBreastCancer
Disease,fibrosis
Extract,mostProminentCause
Other,higherRiskOfBleeding
Other,canBenign
Other,monitoredOnDailyBasis
Disease,PA
Other,differentClinicalOutcomes
Other,invasion
Other,higherDetectionRates
Provision,constitutiveActivationOfDownstreamSignalingPathway
Other,area
Other,prohibitivelyExpensive
Other,haveReportedMainlyAfterMastectomy
Other,similarExperimentalParameters
Other,charts
Other,year
Resistance,increasedCellApoptosis
Exposure,equivalentPerformance
Other,numerousStudies
Other,concernForExistenceOfCancerCellsInGrafts
Other,worldwideHighestAge-standardizedBreastCancerIncidence
Other,needForNodalRadiotherapyInSpecificSituations
Plasticity,sensitivity
Other,localizedDescriptionOfBreastCancer
Disease,triple-negativeBreastCancer
Other,widelyAcceptedAsStandardOfCareFollowingBreastConservation
Disease,neuropathy
Other,eukaryoticTranscriptome
Plasticity,tumorWeight
Other,hasReported
Other,extensiveAttentionOfResearchers
Extract,averageOf425Â±496Ctcs/2Ml
Other,mostSensitiveTest
Other,evolve
Document,literatureForFamiliesWithCdh1Mutations
Other,criticalRole
Other,overviewOfAbbreviatedBreastMriProtocols
Other,STAT1
Other,howeverKnown
Other,Anemia
Other,largeVariability
Other,transferable
Disease,metastaticDisease
Other,relativeHospitalizedBleedingRisk
Other,alcoholConsumption
Distance,firstFiveFacebookOpenBreastCancerGroupsInYear2016
Other,frequentLateRelapses
Other,determinantsOfCancer
Other,182Percecnt
Other,rituximab
Troponins,cardiacTroponins
Other,moreEasilyHypomethylated
Other,cnvData
Other,widelyUsed
Distance,characteristicsInsideTumors
Other,soFarHasMainlyAssociatedWithMutationsInBrca1
Other,an
Other,worldwide
Other,mutationalStatusBesidesFamilyHistory
Other,Lack
Disease,inborn-likeErrorsOfMetabolism
Other,Identification
Other,enhanced
Gene,Progranulin
Mutation,rs5743810
Disease,ductalCarcinoma
Other,worseOutcome
Other,576Percecnt
Other,peripheralBlood
Other,characteristicsOfHighDimensions
Other,township
Other,attention
Other,anti-apoptoticEffectsOfEstradiol
Other,over-represented
Gene,VAP-1
Other,ctcCounts
Other,timeOfTheirAppointmentwithDoctor
Other,Isolation
Other,understand
Other,greatPotentialInDiagnosisTherapyOfCancers
Other,givenRecentConcernsAboutGadolinium-basedContrastAgentsAreAlsoInvestigatedForBreastCancerDiagnosis
Other,radiotherapy
Other,hypomethylation
Neuropathy,commonPrimaryLesion
Other,surgicalOutcome
Images,virtualRecombinedImagesFromLeImages
Appearance,diagnosisAccuracy
Incorporation,two-yearStudy
Other,Mammography
Other,strongLinkage
Lymphedema,developmentOfLymphedema
Other,SNPs
Other,hasEstablished
Other,identification
Other,23Studies
Other,histopathologicFeatures
Other,edition
Plasticity,mass
Other,mammography
Other,currentlyUnclear
Resistance,activity
Other,suggesting
Other,lumbarSegments4-6
Other,chinesePublic
Provision,rangingFromDiagnosisPhaseToControlOfDisease
Other,connection
Other,noninvasiveImaging
Other,otherDietaryRecommendations
Other,genesCodingForTumorSuppressorProteins
Other,yetHasFirmlyEstablishedInClinicalPractice
Other,magneticResonanceImaging
Other,localTherapy
Other,535941Survivors
Other,howeverMuchLower
Obstacle,blockade
Food,documentedAsImportantTumor-promotingAgentForSeveralHumanCarcinomasIncludingBreastCancer
Other,statusOfScreeningWomenWithDenseBreasts
Other,osteopontin-750Accumulation
Other,adulthood
Other,importantCopingResource
Nondestructive,mostNondestructiveTests
Other,times
Other,approximately75PercecntOfBreastCancers
Other,healthcarePolicyMakers
Other,alternativeToFrozenSections
Other,commonCancerTypes
Other,effectiveDiagnosisOfBreastCancer
Other,spindleCells
Other,environmentalFactors
Endocrine,prostateCancerSurvivors
Other,potentialBiomarkerForCancerDiagnosisThanMrnaBiomarkers
Other,mainlyObserved
Other,Stem-likeCells
Other,influences
Other,collection
Other,diffuseGastricCancerPresentedWithClp
Other,earlyDetectionOfSeveralCancerTypes
Exosomes,isolatingExosomes
Interval,totalGroup
Other,interleukin6
Obstacle,lowerCumulativeHazardRates
Sleep,hadDiagnosedWithBreastCancerAtEarlyAge
Other,miR-511
Other,this
Other,operablePatients
Other,capabilities
Hyperglycemia,hyperglycemia
Other,optimalTherapeuticTargetForPatientWithAdvancedBreastCancer
Other,near-infraredLight-controllable
Interference,tripleAssessmentFollowed
Obstacle,barrierFunction
Disease,maleBreastCancer
Other,mir-511Expression
Other,typicalWoman'sDisease
Other,clinicalOutcomesDiffer
Other,hasDescribedInFewHdgcFamilies
Other,relativeThoseOfControls
Other,lessEffective
Other,Demographics
Other,breastCancerCases
Other,classificationOfMammograms
Other,Biopsy
Other,oneCancer
Other,clinicalSettingOfPreviouslyVagueDiagnosisInImaging
Other,featured
Other,proteinKinaseCInhibitors
Dysplasia,finalMultipleRegressionModel
Other,howeverHampered
Other,t2bSutegory
Other,havePublished
Other,responsible
Other,pitfall
Other,roleOfPdgf-b/pdgfr-betaAxisInRareTypesOfBreastCancers
Other,adherenceToEhtAmongBreastCancerPatients
Other,leastAbsoluteShrinkage
Probe,osteopontin-basedProbe
Other,precision
Endocrine,termsOfProlactinNormalizationInPituitaryFunction
Other,significantlyAssociated
Other,vap-1Staining
Other,higherRisk
Other,differentStudies
Resistance,panelOfMonoclonalAntibodiesAgainstNewlyEstablishedCellLine
Other,prognostic
Extracts,leafExtracts
Other,spc24Knockdown
Other,differentOss
Other,hugeVolumes
Disease,RDD
Other,obstetricians
Other,treatedWithIntraperitonealInjectionFor30Days
Other,significantlyDecreased
Other,canDifficult
Other,mostCommonMalignantTumor
Other,treatmentOfTriple-negativeBreastCancerWithConventionalChemotherapeuticAgents
Disease,breastCancerWisconsin
Contraception,20PercecntIncreasedRiskOfBreastCancerAmongCurrentHormonalContraceptionUsers
Other,mda-mb-231Cells
Other,murineMonoclonalAntibodies
Other,15Percecnt
Other,22Patients
Other,us
Relapse,betterOutcomeWithGoodNegativePredictiveValue
Chemical,Aspirin
Plasticity,massMedia
Interference,chronicDebilitatingLifelongComplication
Other,resultsExpression
Other,differentPatientRaces
Other,subacuteEffects
Other,APBI
Other,migrationAbilitiesOfHelaCells
Other,2-3Years
Other,cosmesis
Other,measured
Other,Areas
Other,pi3k-aktSignalingPathway
Complexes,dynamicSh2Domain-scaffoldingProteinComplexes
Other,lessBleedingThanTraditionalVenousThromboembolismInGeneralPopulation
Other,feasibilityStudies
Other,1Year
Drugs,drugs
Incorporation,inStudyDevelopedByCell-selex
Other,associated
Other,riskFactor
Resistance,consistentWithBreastCancerCellResultsSignificantlyInhibited
Other,65Ng/ml
Other,migration
Other,uncover
Other,youngWomen
Other,mayImportantStepsDuringDiagnosis
Incorporation,experimentalStudyOfCryo-stabilityOfCancerCells
Sleep,medianAgeOf50
Other,466Percecnt
Baseline,assessedAtBaseline
Other,we
Other,twoUncommonCasesOfDelayedBreastCancerRelapses
Other,clinicalPractice
Other,life-threatening
Relapse,better
Other,decreasedExpression
Other,proposed
Other,mostCommonCancer
Other,easternAsianMusculoskeletalOncologyGroup
Other,only44Percecnt
Other,haveAssociated
Other,subsequentMalignancies
Other,theirAdjacentMatchedTissues
Plasticity,uterineMass
Other,diagnosticPfBiomarkers
Dysplasia,multivariableLogisticRegressionAnalysis
Skin,skinMetastases
Other,disadvantages
Neuropathy,poorAdhesion
Other,significantlyReduced
Cytology,aspirationCytology
Other,variants
Other,role
Areola,everolimusSideEffects
Other,nf-krab-inducedIncreasedExpressionOfCcnd1
Erythematous,boundErythematousAppearance
Other,approaches
Endocrine,thanFamiliesOfPatientsWithNon-functioningPituitaryAdenomas
Resistance,choiceOfImmunohistochemicalTechniques
Other,postmenopausalWomenWithDevelopmentOfBreastCancer
Other,90PercecntOfPatients
Other,couldEmployed
Other,screening
Skin,twoCasesOfMimicsOfBoneMetastasis
Markers,epigeneticMarkers
Skin,itsExpressionLevel
Markers,adequateSampleForAnalysisOfMolecularMarkersToGuidePatientsWithNon-smallCellLungCancerToAppropriateTargetedTherapies
Other,Speed-of-sound
Other,place
Obstacle,coxProportionalHazardModel
Other,epigeneticAberrations
Other,mortality
Other,643Percecnt
Other,ORR
Other,pb-ctMode
Other,recognizedAsCtcIn1Of15HealthyBloodSamples
Other,context
Other,normalTissues
Other,axillarySurgery
Other,proposedMethod
Quantification,successfulQuantificationOfCa15-3InSerumSamplesFromCancerPatients
Other,geneExpressionData
Glycosylation,glycosylationOfMembraneTypeMr
Other,cross-sectionalCategories
Other,challengingProblem
Other,upregulationOfE-cadherinExpressionLevels
Sleep,womenOfReproductiveAge
Other,ronReceptorTyrosineKinase
Other,independentPrognosticFactor
Other,furtherAdvancements
Other,large-scaleStudies
Food,assay
Extract,benefitOfProtectionAgainstCardiovascularEventsWithPotentialReductionInBreastCancerRisk
Chemical,TAG72
Other,correctDiagnosis
Other,incidenceOfCardiovascularDiseaseAmong32757CancerSurvivors
Other,support
Membrane,panel
Other,metastasis-free
Skin,bone
Other,thenClassifiedBySupportVectorMachines
Other,serumCrust
Other,directTargetGene
Other,patientsWithBreastCancerReceivingWithAnthracyclines
Other,represented
Other,nationalTrials
Other,cancer-relatedDeathsAmongWomen
Distance,shouldIdeallyAdministeredAtLeast1WeekBeforeCommencementOfAlkylatingTreatment
Other,modelling
Other,ICER
Other,tumorSuppressorFunctionOfP53InPathogenesisOfBreastCancer
Other,type160Patients
Other,trastuzumabTherapy
Other,fewStudies
Other,accessToReceptorAnalysesInCytosolAtDiagnosis
Other,measurements
Other,nippleInvolvement
Other,carboxyl-modifiedPegylatedPoly
Other,confirmed
Collision,assessmentOfImpactOfAdvancesInDiagnosisOfPatientsWithBreastCancer
Other,diseases
Other,complexKaryotypes
Other,automaticIntraoperativeIdentificationOfBreastCancerMargins
Other,localExcision/lumpectomy
Other,breastCancerBrainMetastases
Other,determinantGenesRelatedToBreastCancerFromInitialGeneExpressionData
Membrane,membraneTypeMr
Other,Studies
Other,associationsOfFactorsWithLocoregionalAtDiagnosis
Other,womenWorldwide
Other,potentialTarget
Behaviours,positiveChangesInTheirHealthBehaviours
Other,risk
Other,moreAdvancedStagingAtDiagnosisInWomen
Images,microscopicImages
Disease,overallSurvival
Other,humanBreastCancerCells
Other,lowerNewBloodVesselsFormation
Interference,interventionArm
Other,textureAnalysis
Other,february2012InNargisDuttMemorialCancerHospital
Other,goodCorrelationBetweenErAnalysedWithCytAtDiagnosisAnalysedWithIhcInArchivedFfpeTissueFromSameTumour
Other,mriTechniques
Other,robustSynthesisMethods
Plasticity,massProduction
Other,developmentOfBrainCancers
Other,grafts
Appearance,orderOfAppearanceFrequency
Other,advantageOfHigh-throughputLuminexTechnique
Other,50PercecntRelapsedTissues
Other,mastectomizedWomen
Other,breastCancerIncidence
Other,11BreastRadiologists
Other,outpatientClinic
Other,inAdditionMeasured
Other,gtpaseInBreastCancerCells
Other,routineProcedure
Other,arms
Other,growthPotential
Other,patternsOfAssociationResults
Other,herDisease
Other,thereforeAdministered
Other,largeNumberOfTumor-freeData
Other,cancerFibroblasts
Other,muchInterest
Other,expressedSeparately
Resistance,drugResistanceOf
Other,well-establishedTreatment
Other,singleSmallIncision
Other,Follow-up
Other,system
Other,higher-qualityImaging
Other,now89Years
Quantification,feasibleInProperlySelectedCasesWithAsymptomaticNeuromasAfterAccurateTissueSampling
Other,predictive
Other,11Days
Other,richSpectralFeaturesOfPhenyboronicAcid-basedNanoprobe
Other,mostBreastDiseases
Other,mostLikelyParaneoplastic
Other,steps
Other,Importantly
Sleep,furthermoreDiagnosedWithPaAtEarlierAgeThanPatientsWithNegativeFamilyHistory
Other,breastCancerGrading
Other,annexinV-fluoresceinIsothiocyanate/propidiumIodide
Interval,imageQuality
Other,resectedPrimaryLungCancer
Other,combination
Gene,Mfn1
Other,hasMadeInMolecularSubtypingOfBreastCancer
Other,performedFromInceptionToJanuary312018
Other,SpCM
Other,underlyingCauses
Disease,Tumours
Other,statisticalClassifiers
Resistance,significantAntiproliferativeActivityAgainstHumanTumorCellLines
Other,tumorSuppressorFunction
Other,quantitative
Chemical,DDE
Other,clinicalCharacteristicsOfCareOfBreastCancerPatients
Resistance,chemotherapyResistance
Endocrine,treatmentOfHormoneReceptor-positiveBreastCancer
Interval,increasingCellCycleGeneExpression
Other,oftenHypomethylated
Chemical,baicalin
Other,adipocytes
Extract,mostCommonExtrinsicCause
Other,mrSystems
Other,alteredInHumanBreastCarcinoma
Other,rapidAdvancements
Exposure,discovery
Other,use
Other,evolutionaryConservedCircularRnas
Chemical,Cabergoline
DNA,dnaMethylationDifferencesBetweenTumorBreastTissue
Other,whenActiveUse
Other,foundInPcosCohortThanInComparisonCohort
Food,betterAccessToAtertiaryCancerCenter
Other,principles
Other,fourSelectedPopulation-basedCancerRegistries
Other,pcrResults
Other,remarkableImprovements
Other,humanBody
Other,occultBreastTumors
Other,of121Patients
Other,growing
Document,nomogram
Other,therapies
Resistance,lungCellCarcinomas
Other,100Patients
Other,dependent
Other,46NsclcPatientsBeforeChemotherapy
Other,water
Plasticity,976PercecntSensitivity
Other,fpReductionTechnique
Other,concerned
Other,first-lineTreatment
Applicability,clinicalApplicability
Other,oneHundredElevenPatients
Other,efforts
Other,inverseProblem
Other,throughOptimizationTestsChosenAsOptimalConditions
Other,radiomics
Other,inconsistentResults
Other,only1ulOfSerumSample
Isolation,clinicalFeasibilityOfCtcIsolation
Other,emergingPublicHealthProblemInLowCountries
Obstacle,summaryHazardRatios
Gene,TTF-1
Other,brcanessPhenotypeInBrca1Wild-typeCells
Other,informationalNeedsByCancerType
Other,speed
Skin,clinicalSecondLevelExamination
Other,willDifferent
Other,futureDirections
Other,oncologyGroup
Other,hasUsed
Plasticity,massSize
Interference,postAssessment
Other,they
Other,mir-193b-3pIdentifiedAsRegulator
Other,associationBetweenRace/colorInWomenWithBreastCancer
Other,Israel
Provision,activationOfOther
Other,preclinicalModels
Quantification,whole-tumorSamplingOfDiseaseBurden
Other,preservationOfBiomarkerExpressionInOldFfpeTumour
Other,canCategorizedIntoSubtypesOfLuminalA
Cytology,histology
Other,correspondingCohort
Other,mostCommonAdultCancersInKenya
Interference,urgentlyAdvanceImplementation
Other,right4
Other,needForAnalysisOfMetastaticTissuesAtRecurrence
Provision,leadingCauseOfMorbidityWorldwideYetMethodsForEarlyDetection
Other,cruciferousVegetables
Other,symptomaticWomen
Other,infiltrationSimilar
Covariance,covariance
Other,healthInitiative
Other,relationship
Other,challenges
Lymphedema,secondaryLymphedema
Other,505PercecntOfAnalyzedCases
Other,highlyExpressed
Other,highestIncidenceAmongMalignanciesDiagnosedInWomen
Probe,probeNir-sn-ggt
Other,specificSubtype
Other,primaryBreastCarcinoma
Nondestructive,nondestructiveTesting
Other,selectedPopulationsOfAfricanPatients
Disease,chorea
Other,breastSurgery
Other,willDifferentRegardingSubtypeAtDiagnosis
Document,nsaidsExposure
Other,extendedAdjuvantTreatment
Other,mistaken
Other,meta-analyses
Distance,focalAsymmetricDensity
Other,additionalAnti-her2Therapy
Other,twoIndependentReviewers
Nondestructive,byWhichObservedInNondestructiveWayThroughThermalAnalysis
Other,methylationStatus
Other,interpretation
Other,triple-negativeSubtypeMda-mb-231Cells
Other,mothers
Complications,occasionalComplications
Other,survivalDifferences
Disease,heartFailure
Other,familyMemberAffectedWithCancer
Other,oncogene
Hyperglycemia,effectOfBaicalinInBreastCancer
Other,pathologicEvaluation
Provision,cytokineFunctionsLeadingToDevelopmentOfCancers
Other,search
Disease,seromaProduction
Other,importantComponentOfMitoticCheckpointMachineryHaveShownInSeveralCancersIncludingAnaplasticThyroidCancer
Other,retrieved
Resistance,drugResistance
Other,potentiallyCurativeRegimensOfCancerChemotherapy
Other,autopsyStudies
Other,successOfSymmetricPositiveDefiniteMatrices
Other,subsequentCancerCounselingOfFemaleSurvivors
Other,diagnosisSystem
Other,reality
Other,highlyEffective
Other,complementaryApproaches
Other,strongFamilyHistoryOfCancer
Other,CA-VTE
Other,discovered
Appearance,appearance
Gene,HER2
Other,additionalIndicator
Other,segments
Other,less-effectiveChemotherapyAgents
Plasticity,lowDiagnosticSensitivityForWomenWithDenseBreasts
Other,hampered
Other,haveObserved
Other,significantCausativeGenes
Other,molecularTesting
Other,genitalTract'sMetastases
Other,ironOxideNanoparticles
Appearance,caseReport
Interval,energyImage
Other,efficacy
Other,disseminatedDisease
Scoring,nuclearAtypiaScoring
Other,anotherOfSeveralIndividualsInOneFamilyAffectedByCs
Other,CNVs
Other,histologicExamination
Other,capacities
Other,lung/bronchusMalignancies
Other,anticipatedOutcome
Other,homologousRecombinationPathway
Other,sonography
Other,Review
Other,trialsOfHer2-targetedTherapiesIn
Other,tnmStaging
Other,fxyd3Amplification
Other,analyzed
Other,haveBackboneOfSuchEnormousStridesOfAu
Other,establishedOncogene
Other,textureFeatures
Other,2002
Disease,macroprolactinomas
Other,earlyBreastCancer
Other,prevalenceOfobesityOf277Percecnt
Other,tumorSuppressorMir-10aInCells
Skin,balfLevel
MSOT,msotImaging
Other,exposed
Other,previousStudies
Other,forThoseWithNormalLvef93Percecnt
Other,adjustedProportion
Other,biologicallyDifferentDiseaseInWomen
Other,furtherUnderstanding
Other,furthermoreHaveSuggestedAsPotentialCirculatingNoninvasiveBiomarkersForEarlyDetectionOfGastricCancers
Sleep,duringAgeAssociatedWithIncreaseOf8MoreFemaleBreastCancerCasesPer100000DuringAge50-54
Other,negativeMargins
Other,her2-positiveEarlyPatients
Other,fewLmics
Other,P
Craniotomy,craniotomy
Mastectomies,bilateralMastectomies
Other,associatedWithBreastCancerRisk
Other,highCorrelation
Hyperglycemia,highlyProblematicDose-limitingEffect
Other,greaterthan1500Pg/ml
Other,simulationStudies
Food,specificFoodRecommendations
Probe,probe
Other,rolePlayedByPdgfFamilyMembersInNormalDevelopmentOfBreastTissueDespiteItsPotentPro-lymphangiogenicEffects
Disease,death
Other,interactionEffects
Other,isReplacedWithRadiotherapyInSituations
Gene,BRCC3
Other,cardiotoxicRisk
Other,humanErrors
Other,particularEmphasisQuantifying
Other,GTPase
Other,expected
Other,strongIndependentPrognosticFactor
Other,aberrances
Other,107ObservationalStudies
Other,weak
Other,largerStudies
Plasticity,plasticity
Other,centralRoleInBreastCancerResearch
Collision,familyImpact
Disruption,postponementVisiting
Other,patients'MedicalRecordsFromOctober2007ToDecember2012
Endocrine,earlyDetectionOfProstateCancer
Other,sutegories
Other,numberOfLong-termSurvivors
Other,pathogenic
Resistance,heterogeneousExpressionOfHumanEpidermalGrowthFactorReceptor2OnIndividualCancerCellSurface
Other,pax6Inhibition
Late-stage,late-stage
Other,testing
Other,risingTrendInMajorityOfLmics
Other,mainObjective
Other,severePneumopathy
Quantification,quantification
Other,unitedKingdom
Other,theirVariousness
Other,twoGroups
Derivatives,tripentoneDerivatives
Other,hasIncorporatedIntoClinicalPracticeForOver100YearsAtLowCost
Other,evidencedByIncreaseInContrastAfterInjection
Other,label-freeDetection
Other,resultOfPreviousOrbitalBiopsy
Other,currentBio-sensingTechniques
Other,thusImportant
Markers,mightMetastaticCrcMarkers
Other,proteins
Other,intralaboratoryValidationSet
Other,ultrasound-guidedDiffuseOpticalTomography
Resistance,potentialApplicationForDiagnosisOfCancerInFuture
Chemical,estrogens
Sleep,possibleCorrelationsWithClinicalStatusIncludingAge
Other,quantified
Surgeries,complexSurgeries
Other,inHumanBreastCancerHasReported
Other,alsoSignificantlyLower
Other,sampleSizes
Other,importantlyCouldPotentialDiagnosticBiomarkerInEthnicPopulation
Other,WHI
Other,unenhancedMriTechniques
Other,commonComplaint
Other,suchSymptoms
Other,experts
Other,occurrence
Other,microscopicTesting
Other,shouldStaged
Other,exactTest
Aptamer,ssdnaAptamerMf3
Other,cancerDiagnosis
Other,itsWidespreadUse
Other,ourPatient
Other,hazards
Resistance,cell
Other,hospitalizedBleedingRisk
Other,pharmacologicalInduction
Skin,at25HPost-injectionGreaterInTumorBedThanInKidneyRespectively
Other,commonMedications
Contraception,hormonalContraceptionUse
Other,pax6MethylationStatus
Other,well-established
Disease,osteolyticLesion
Other,usuallyDiscoveredIncidentally
Other,update
Other,dependentOnRigorousPathologicEvaluationOnAdministrationOfTreatmentDictatedByTumorBiology
Other,secondSurgery
Other,mainlyExpressed
Other,improvedDetection
Other,womenCarriers
Other,couldConsidered
Other,65-year-oldFemale
Disease,cancer-relateddeaths
Food,itParticularlyAttractiveAsPotentialAgentInBreastCancerPrevention
Other,PB-DLL
Other,theirRisk
Other,three-yearSurvivalRates
Other,nano-biosensor
Other,connected
Other,mainContribution
Appearance,characteristicExosomalTumorMarkers
Other,tested
Other,preventiveStrategies
Other,mab1e3
Other,syndrome
Other,mass/es
Other,positronEmissionTomography
Other,20BreastCancerPatients
Other,linked
Other,about1Year
Resistance,conflict
Other,predominantlyCystic
Other,treatmentTherapy
Other,patient'sOutcomeOverCosts
Other,illiterate
Other,ASSIA
Other,sequelae
Interference,disposition
Lymphedema,outcomeInLymphedemaPatients
Other,imagingInvestigations
Cavernous,cavernousMalformation
Other,analysisOfLncrnaExpressionProfiles
Other,414Percecnt
Other,inhibitors
Other,plasmaLevels
Other,hybridCultures
Other,monitored
Other,higherProportion
Other,willUsedAsReferences
Other,least
Other,oxidationPeakCurrent
Other,termsOfKyotoEncyclopediaOfGenes
Other,RON
Other,pathways
Skin,expressionLevel
Other,ca15-3ByCmia
Disease,neurologicalDisorders
Infrared,infraredFluorescentImagingInTripleNegativeInVitro
Other,vitalRoles
Other,importantIntercellularSignalingRegulatorWithExpressionCorrelation
Other,ODV
Other,cells
Other,shouldCo-managed
Chemical,paclitaxel
Resistance,associationsOfPhysicalActivityInGlobalHealthInBreastCancerSurvivors
Other,volumes
Resistance,tamoxifenResistance
Other,canStressful
Provision,medianFollow-upOf48Years
Other,0.029
Other,tumorImaging
Other,withandControllingForTreatmentDelays
Other,2/149
Other,moreLikely
Other,moreCommonlyDiagnosed
Exposure,reportOnPerformanceOfBayesClassifiersLikeTreeAugmentedNaiveBayes
Other,alarm
Other,diagnosisOfEstrogenReceptor
Resistance,theirEffectsOnHumanBreastCancerMda-mb-231CellGrowthInhibition
Other,trendsInUkCancerIncidenceByCancerSite
Other,increases
Other,riskOfEndometrialPathologies
Other,urgent
Other,thromboembolicEvents
Other,number
Other,howeverSwitched
Other,21Percecnt
Incorporation,third-lineTreatmentForAdvancedTriple-negativeBreastCancerthisRetrospectiveStudy
Other,metabricTrainingSet
Malformation,malformationInduction
Other,canStressfulToPatient
Other,byMultivariateAnalysisSignificantIndependentPrognosticFactorOfOs
Other,currentEvidenceOnEfficacyOfHer2-targetedTherapiesInOlderAdultsWith
Other,neglected
Other,promisingBiomarkers
Other,metastaticDisease
Other,usStandardization
Other,earlyStageDiagnosisOfTumors
Gene,PCDH10
Other,9398
Other,breastCancerDetectionMethod
Other,cancerCare
Sleep,threeYearsBeforeAge64Years
Other,breastCancerGenes
Craniotomy,surgicalExcision
Other,characterized
Dysplasia,coxRegressionAnalyses
Other,primaryTumours
Other,fisherAnalysis
Other,subtypes
Other,lessVisits
Other,mpMRI
Food,expressionOfItsTargetProteinCytokine-inducedApoptosisInhibitor1
Other,neonatalOfRetrospectiveCohortOfPregnantWomenWith
Other,rareCases
Other,randomisedTrials
Other,described
Other,significantlyLower
Other,shorterRadiotherapyRegimens
Markers,tumorMarkers
Other,advances
Other,major
Other,trendForLessRadicalSurgicalApproachesInBreastCancer
Other,breastCancerPatientsWithParticularReferenceToOverallSurvivalAndrecurrenceFreeSurvivalAmongBreastCancerPatients
Other,australianSynchrotron
Other,continuousDynamicCyclesOfFission
Other,outcomes
Other,alexnetModels
Carcinoma,inflammatoryCarcinoma
Other,developmentOfClinicalDecisionSupportSystemsForBreastCancerDiagnosis
Other,receptorActivator
Probe,remarkableEnzyme-activatedNirFluorescentProbeNir-sn-ggt
Exposure,itsPerformance
Other,each
Other,recursiveFeatureElimination
Other,bt549Cells
Other,events
Other,greaterthanorequalto10PercecntReductionInLvef
Other,members
Traumatic,traumaticBreastNeuromas
Endocrine,commonlyUsedAntihormonalTherapyInTreatmentOfBreastCancerInPostmenopausalWomenSpecificallyInTreatmentOfHormoneReceptor-positiveBreastCancer
Other,allow
Other,factorsRelatedToPresenceOfMetastaticDiseaseAtDiagnosis
Other,lymphNodeRatio
Other,theirLong-termSurvival
Other,90Percecnt
Other,cystic
Users,non-nsaidUsers
Gene,VDR
Other,size
Other,mostFrequentCancer
Other,Genetic
Other,her2/hrTripleNegativeTnmStages
Other,diagnosis
Other,methodologyOfInstitutoDeEvaluaciÃ³nTecnolÃ³gicaEnSalud
Disease,invasiveDuctalCarcinoma
Other,treatmentMoreAccessibleToBreastCancerPatients
Other,240Months
Exposure,limitedPerformanceForWomenWithDenseBreasts
Other,symptom
Disease,acromegaly
Other,theirOriginallyTargetedPopulationsOfBreastCancer
Other,importantAspect
Provision,canDetectedWithHelpOfVariousProfilingMethods
Other,miRNAs
Other,causes
Other,immunocaptureOfMarker
Other,Data
Other,correlation
Other,regulationOfEnergyMetabolism
Other,fisherDiscriminantAnalysis
Other,values
Other,importantContributors
Other,examinations
Lifestyle,three-lncrnaSignature
Other,95PercecntCi646-779Percecnt
Other,variousStimuli
Other,2651StudiesIdentified
Other,hasFocusedOnTumourCellsPrimarily
Other,differentLong-termSurvival
Other,negativeIndicator
Other,uterus
Derivatives,activeDerivatives
Other,classifiers
Other,percecntRelapsedTissues
Other,trastuzumab/pertuzumab/taxane
Markers,markers
Provision,personalizedFollow-upSchemes
Other,risk-reducingStrategies
Other,subset
Quantification,successfulQuantification
Other,brca1Levels
Other,clarify
Obstacle,majorObstacleInTreatmentOfTriple-negativeBreastCancerWithConventionalChemotherapeuticAgents
Other,severalPatients
Provision,secondLeadingCause
Other,riskForRecurrence
Other,120BreastCancerPatients
Species,mice
Other,training
Other,shapes
Other,previousTherapy
Other,RL
Probe,fluorescenceMicroscopy
Other,32620MatchedPatientsWithoutPcos
Other,cellDeath
Other,realStatusOfPrs
Other,visualizedTheranosticsOfTumors
Other,mastitis
Other,CMIA
Other,developmentOfPolicies
Other,tumorigenesisOfBreastCancer
Other,3-timeAssessments
Other,important
Incorporation,descriptiveStudy
Document,formOfApoptosis
Other,Cell
Other,profiles
Other,five
Other,random-samplingMethod
Other,inherited
Other,SE
Other,lymphNodeMetastasisInPatientsWithBreastCancer
Other,multipleMitochondrialMetabolicPathways
Interference,delivery
Other,alsoShaped
Other,dryness
Other,treatedWithCapecitabineMonotherapyAsThird-lineTherapy
Other,severalOtherGenes
Other,hidden
Other,neoadjuvantChemotherapyGroups
Other,concentrationsOfVegf-aInComparisonToCa15-3InBreastCancer
Other,DPV
Other,failure
Interval,postmenopausalPeriodWithDopamineAgonists
Resistance,activityOfCellProliferationInBreastCancerCells
Other,normalDucts
Other,bioinformaticAnalysis
Resistance,bl1Cell
Other,meanTime
Analytics,dataAnalytics
Skin,cut-offBalfLevel
Other,familyOfNoncodingRnas
Other,trastuzumab
Other,10Mg/kg
Other,logisticregressions
Other,selectedOptimalFeatureSubsets
Other,supplements
Other,mutationRatio
Other,hasRecentlyDeveloped
Other,greaterthanorequaltoReduction
Other,12-15Percecnt
Other,conventionalMagneticResonanceImaging
Polymorphisms,polymorphismsImportant
Other,bevacizumab-relatedCardiotoxicity
Other,typicalWoman
Species,Patients
Interval,medianInterval
Other,comparable
Other,Resurgery
Other,archivedFormalin-fixedParaffin-embeddedTissue
Other,rare
Other,synchrotronRadiation
Other,veryComplexDisease
Other,typicalFeaturesIncludingFibrocysticBreastDisease
Other,managementOfTumour-relatedSymptoms
Other,roleOfSupportOfferedByVirtualCommunitiesToBreastCancerPatients
Provision,follow-upSchemes
Other,associations
Other,knownHeterogeneousDisease
Other,uptake
Other,heterogeneousPopulationsOfCellsWithHierarchicalOrganizationDrivenByCancerStemCells
Other,westernizedCountries
Other,histopathologicallyProvedBreastTumors
Other,percentage
Other,outcome
Other,stromalExpression
Obstacle,coxHazardRegressionAnalysis
Other,largelyUnknown
Other,satisfied
Other,mustIndividualized
Other,haveProven
Other,normalSamples
Other,84Patients
Other,guidedImagery
Other,IC
Other,ourResults
Other,canDetected
Other,l-3
Skin,skinMetastasis
Other,sparseCombinationOfRiemannianDictionaryAtoms
Other,type
Other,91Percecnt
Other,type1Diabetes
Other,synthesized
Other,imagery
Other,mechanisms
Other,prognosis
Other,patients'MedicalRecords
Other,consolidativeRadiotherapy
Other,hospitalFromJanuary2016ToFebruary2017
Other,mir-511Overexpression
Other,documented
Other,survey
Other,spanishWomenWithLungCancer
Appearance,inConclusionPathogenicFeatureInPrimarySamples
Other,maySteps
Incorporation,presentedWorkForFeatureExtraction
Other,promisingNoninvasiveBiomarkerForDetectionOfDiseases
Other,recruitmentOfOlderAdults
Other,aberrations
Other,nowAlsoWidelyUsed
Resistance,leafMda-mb-231CellDeath
Other,breastCancerAged
Other,independent
Incorporation,ourStudy
Other,S10
Other,qualityOfLife
Other,isReplaced
Other,initiationOfPromptTherapy
Other,misdiagnosis
Other,vitalRole
Other,henceMainlyBased
Other,oneSpecificSubtype
Other,oncologicRisk
Other,noted
Other,increasedRiskOfLong-termIncidentcvd
Incorporation,ourPreviousWorkRegardingToPropertiesOfPluronicsWithDifferentPhotosensitizerForPhotodynamicTherapy
Provision,control
Complications,complications
Other,SVM
Other,percecntConfidenceIntervals
Other,objectives
Other,hasDeveloped
Other,positiveChanges
Other,accurateDiagnosisOfBreastCancerSubtypes
Other,iraqiWomenWhencomparedToWesternWorld
Other,firmlyPlaceWithRecentTrendsTowardDecreasedRatesOfRe-excision
Other,dualRole
Document,coxModel
Gene,FOXC1
Other,moreRefinedStratificationThanAnatomicStageAlone
Other,mostEuropeanCountries
Other,moodOfLife
Other,validatedAlgorithms
Other,widelyUtilized
Other,biologicalSubtypes
Other,largeBreastCancerTissueMicroarray
Quantification,multidimensionalScaling
Other,member
Other,presented
Other,findings
Other,maintainedBreastCancerDatabase
Other,secondLargestHmo
Other,haveYetProven
Other,99Percecnt
Other,consistent
Other,femalePatients
Gene,CK5
Other,notablyUpregulatedWithinPatients
Other,advance
Other,sectionLeads
Other,ductalCarcinoma
Disease,breastCancerStaging
Other,1722Comments
Other,changes
Other,suggested
Other,most
Other,canineTumours
Extract,cssBenefit
Other,secondaryLymphomatousInvolvement
Other,urgentlyNeeded
Other,breastCancerScreeningProgramme
Other,Residents
Other,mostCommonCancerInWomen
Gene,Protocadherin-10
Other,factorAnalysis
Other,subsequentLung/bronchusMalignancies
Other,elusive
Other,theirInteractionsLikeGene-gene
Drugs,conventionalChemotherapyDrugs
Other,kaplanMeierCurves
Other,49Patients
Other,pcosGroups
Baseline,reducedBaselineLvef
Other,Researchers
Other,variation
Endocrine,patientsWithProstateCancer
Other,divided
Other,molecularChanges
Other,ultrasound
Other,postmenopausalWomen
Other,online
Other,missed
Other,diagnosticEvaluation
Other,part
Other,gsAlgorithm
Other,development
Other,surrogates
Other,relativesOfPatientsWithPa
Species,children
Other,delay
Interval,cellCycleArrestFollowedByMassiveCellDeath
Provision,exercise
Other,immunohistochemicalProliferationMarkerKi67
Other,understandingOfEmergingConceptsOfTumorBiology
Other,histoneModifications
Disease,PCOS
Other,differentBreastCancerMolecularSubtypes
Other,diagnosisOfAcuteCoronarySyndromes
Other,stageIv
Other,surveillanceData
Other,oneYear
Other,potentialMechanism
Other,713PercecntWithHighHeterogeneity
Other,healthCareSector
Other,offered
Disease,CLP
Other,totalOf121Patients
Document,estrogenicExposure
Other,measurementSystem
Other,iterativelyModified
Other,tumorSite-specificInformation
Plasticity,massSpectrometry
Other,signalTransductionMoleculesIncludingProteinKinaseC
Other,severalHer2-targetedTherapies
Resistance,weakToStrongReactivityToOtherCellLines
Other,recentYears
Other,significantlyProlongedMedianPfs
Other,clinicalVisits
Other,complaint
Membrane,paraneoplasticAntibodyPanel
Exosomes,ca125-richExosomes
Other,proteinExpression
Other,earlyDiagnosisOfCancerPatients
Other,classified
Distance,eConcentration
Other,modulated
Other,separateClassificationModels
Other,brcc3Expression
Other,knowledgeGaps
Other,reduction
Document,exponentialTiltingSemiparametricModelAccountForNonignorableMissingDataMechanism
Other,fewerInstancesOfSpreadToLungs
Other,processing
Other,annualMammographyAssociatedWithEchography
Other,thenAdded
Food,multiplexAssay
Other,currentTherapiesAvailable
Other,It
Endocrine,largeCohortOfPatientsWithPituitaryAdenomasInOutpatientClinic
Other,hasUsedInLeukemia
Interval,axillaryClearance
Incidence,incidenceRates
Other,inImaging
Other,recommended
Other,shouldProcessed
Membrane,atrophiedVaginalMucosa
Other,itsDeregulation
Other,mappedToPatientPathway
Other,coverageRates
Other,outliers
Other,variousNon-pharmacologicalAdjuvantTherapies
Resistance,bl1CellMda-mb-468
Other,insufficient
Other,familialCancerClusteringInPatientsWithProlactinoma
Interval,enhancementOfImage
Other,51Days
Pediatric,pediatricPopulation
Other,cases
Other,youngerBreastCancerSurvivors
Other,advancedBreastCancerBearingMutationsInGenesInvolvedInPi3k/ark/mtorSignalingPathway
Gene,FXYD3
Other,longitudinalAssociation
Other,closelyAssociated
Other,inColorectalCancersHaveConducted
Interference,postOperativeAssessment
Other,relatedTranscriptionFactorSox9
Resistance,breastCancerCellInvasion
Endocrine,menopausalHormoneTherapy
Other,secondTumor
Interval,cycle
Interval,highestSeInTotalGroup
Appearance,accuracyOfLesionDetection
Endocrine,evidenceForEfficacyOfGonadotropin-releasingHormoneAgonists
Other,femalePatientsWithAd
Other,recentDevelopments
Other,immediateUnmetNeedInClinicalPractice
Other,nanoparticels
Other,termsOfMechanism
Other,informationNeedsVary
Other,seen
Other,hasApplied
Disease,boneLoss
Other,t-MDS
Other,metastatic
Other,news
Other,mPatients
Other,analysisInvestigate
Exposure,excellentPerformance
Other,sexualityEvidence
Other,datasets
Other,qualitativeApproach
Other,highestRisk
Other,differentiallyModulated
Incorporation,presentStudy
Other,youngestCohort
Other,similar
Other,novelInsightsIntoEpigeneticEvents
Other,DCR
Other,treatmentProtocols
Interval,overPeriod2008-2012RegisteredInOlderAdultsInFourPopulations
Other,veryRareCases
Other,diverseMalignantTumors
Other,chemotherapyGroups
Chemical,Estrogen
Other,incidenceOfCancer
Other,patient'sHistory
Other,balfOfNsclcPatients
Extract,commonCauseOfMorbidity
Neuropathy,18-fdgFlux
Other,mirnaExpressionProfiles
Other,highlightConsiderations
Other,1999-2011
Other,splenicLymphocytes
Other,particularlyPatientsWithDenseBreastTissue
Food,ourExperienceOfHigh-doseRadiotherapy
Other,advantage
Other,0.001
Other,SCs
Species,people
Other,Development
Other,significance
Food,atEndOfFollow-upClassifiedRegardingTheirAdherenceToRecommendationsForCancerPrevention
Other,cancerCareSystems
Exposure,performanceEvaluation
Endocrine,dealingWithEndocrineResistanceInPatientsWithBreastCancer
Other,cxcSubtypeOfChemokineSuperfamily
Disease,toxicity
Other,inverseLongitudinalAssociation
Other,probableAnticancerMechanisms
Other,switched
Distance,sinceItsFirstDescriptionAtInstituteOfPathologyInKielAgoHasShown
Other,known
Other,correlativeEntities
Other,olderAdultsWith
Other,usualCare
Interval,chineseExpertGroup
Membrane,antibodyPanel
Other,assessedinclusionCriteriaForEnrolment
Other,researchers
Other,reference
Other,histopathologicalreports
Other,CNN
Other,withFourier-domainReconstruction
Other,importantComponent
Incorporation,retrospectiveStudyOfWomenTreatedWithTrastuzumabForHumanEpidermalGrowthFactorReceptor2BreastCancerAtMayoClinicBetweenJanuary12000
Other,randomlyDivided
Other,extremelyRare
Other,protocols
Other,mostFrequentMalignancy
Other,ck5/6
Other,program
Other,likelyParaneoplastic
Other,serious
Neuropathy,mayIndicativeOfBenignLesion
Other,suutaneousBreastTumor
Species,participants
Other,regulationMechanisms
Disease,hyperthermia
Other,antibodyHerceptin
Other,locoregionalRadiotherapy
Other,inAdditionFurtherConfirmedInEarlyStage
Other,alveolar-interstitialLesions
Other,diagnosticChallenge
Other,historyPhysicalExamFindings
Other,tumorAccumulation
Disease,hematologicalMalignancy
Other,patient'sTumorBurden
Other,sensitiveNano-genosensor
Drugs,developmentOfEffectiveDrugsForTreatmentOfHormone-dependentBreastCancer
Other,Report
Dioxide,carbonDioxideLaserTechnology
Other,cpgIslands
Other,Depletion
Other,differentPhotosensitizerForPhotodynamicTherapy
Document,content
Disease,tumour
Resection,Resection
Other,SRS
Sleep,currentUsersOfLongerDuration
Other,realDataAnalysis
Other,sexes
Other,contexts
Other,overnight
Individuals,Individuals
Other,NLR
Other,preciseToolForTargetedTreatmentOfCancerIncluding
Other,roboticSurgicalSystems
Other,theResulting
Other,Ontario
Collision,theirQuestionableImpactOnMortalityOnIncidenceOfAdvancedTumors
Other,kind
Other,patientsWithMetastaticBreastCancer
Hyperglycemia,managedWithPalliativeRightHemicolectomyInViewOfConstipationAsSystemicTreatment
Other,significantAdvances
Behaviours,healthBehaviours
Other,elevatedMitochondrialFission
Other,earlierAges
Other,life
Document,questionnaireBasedOnAnderson'SdelayModel
Cytology,fine-needleAspirationCytology
Other,inflammatoryBreastDiseaseWithUnknownEtiology
Other,pdgfs/pdgfrsAxis
Gene,PAX8
Other,detectedThroughScreeningThroughSigns
Appearance,dataForAccuracy
Other,poly
Other,therapeuticTargetForPotentialTreatment
Other,importantPotential
Other,treatmentCompletion
Other,medications
Sleep,medianAge
Other,novelPowerfulTechnique
Other,majorConcerns
Disease,brainMetastasis
Other,normalCardiacFunction
Other,markedlyUp-regulated
Appearance,diagnosticAccuracy
Other,iU22
Other,mriImaging
Relapse,betterPrognosisInBl1Patients
Provision,follow-up
Other,termsOfClassification
Other,understanding
Similarities,similaritiesInInformationalNeedsByCancerType
Other,nationwideSurvey
Other,Access
Other,mortalityRates
Other,ways
Other,breastImagingModality
Other,systematicReview
Other,evaluatedInVivo
Other,five-yearOsRate
Other,filipinoWomen
Other,sentinelNodeBiopsy
Other,186S
Other,factor-1Scores
Other,Uganda
Other,distinction
Skin,geneExpressionLevel
Other,threeKindsOfAlgorithms
Lymphedema,higherProportionOfPatientsWithLymphedema
Other,mostSensitiveTestForBreastCancerDetection
Other,comprehensiveSearch
Other,frequentInformationalNeeds
Other,kaplan-meierCurves
Food,ourExperience
Other,CLB-Pt-CLB
Other,encapsulatedSuperparamagneticIronOxideNanoparticles
Other,countries
Other,pseudotumoralAspect
Other,preventionOfBreastCancer
Other,demonstrate
Other,proposedTechniqueResults
Other,included.When
Other,mostInvasiveDisease
Other,higherRisksOfTreatmentDelays
Other,mainTwoEntities
Obstacle,brcc3Interference
Extract,leafExtract
Other,complexTreatmentAlgorithms
Disease,cytotoxicity
Provision,thusInRecentYearsDemand
Other,ovarianMetastases
Other,leaves
Other,prophylacticCranialIrradiation
Interference,theirBeliefsRegardingCancerCausation
Other,matched
Other,canDetectedInManyBodyFluidsIncludingSerum/plasmaSamples
Disease,Cancer
Other,novelTargetedTherapeuticOptions
Other,flowCytometry
Other,Kenya
Other,incidence
Disruption,perturbation
Other,EMT
Other,brainMetastases
Other,osRate
Other,MortalityRates
Other,twoLargeBreastCancerDatabases
Other,utility
Other,theirLimitedAccess
Other,sites
Other,relation
Other,switch
Other,alsoUsed
Other,unclear
Other,ages
Other,diet
Other,substantialDiscordancesBetweenPrimaryTumors
Other,estimated
Collision,typeOfCollisionTumor
Other,40
Other,-1
Other,CESM
Other,ai-associatedTendinopathy
Food,hotIssueInFieldOfCancerClassification
Other,186Pathology-provenS
Other,frequency
Other,potentialBiomarker
Other,mildHyperthermia
Other,canIncluded
Other,ernGenturis
Other,late-phaseClinicalTrials
Other,elusiveToTargetedTherapies-theTriple-negativeBreastCancer
Other,essentialsBleedingRisk
Other,inContextAppliedInClinicalDiagnosticsInClinicalTrialsForPurposeOfStratification
Other,fiveDoses
Provision,base
Other,uterine
Other,risk-stratifiedScreeningStrategy
Other,palliativeChemotherapy
Endocrine,antihormonalTherapyForHormoneReceptor-positiveBreastCancer
PET/CT,subgroupAnalysispleuroparenchymalAnomaliesRateDetectedOnF-fdgPet/ct
Other,functionalizationStepsForRapidDetection
Other,healthcareUtilization
Other,generalPopulation
Neuromas,breastNeuromas
Other,applicationsOfRadiomics
Other,threeOverallSurvival
Probe,novelNear-infraredNirFluorescentProbe
Resistance,proliferationOfThreeCancerCellLinesWithLowIc
Other,patientsOnAromataseInhibitors
Other,jak-statPathway
Other,publicHealthCareSystem
Gene,CXCR4
Other,highlightImportantConsiderations
Other,eighthEdition
Other,placed
Other,solved
Other,aboveConditions
Other,chapter
Other,simulatedBreastCancer
Appearance,accuracy
Other,inflammatory
Other,metastasesFromDistantPrimaryTumors
Other,identifiablePcrResults
Other,lack
Gene,SPC24
Other,surgery
Other,alsoAssociated
Other,breastCancerPatientsSerum
Other,workflowConsistingOfImmunoaffinityPurification
Appearance,theirAbilityOfPrognosisPredictionInTheirOriginallyTargetedPopulationsOfBreastCancer
Issues,issuesRelatedToTherapeuticSequencingInLocalTherapyOfBreastCancer
Other,trueRisk
Resistance,transmembraneCellDeaths
Other,thereforeApplied
Other,breast
Dysplasia,kaplan-meierRegressionMethods
Other,133BreastCancerCases
Other,0.32
Other,obstetrician
Other,89Years
Other,capecitabineRegimenAsThird-lineTreatmentForAdvancedTriple-negativeBreastCancer
Other,evidenceOffer
Other,cutoff
Other,rareTumor
Interval,controlGroup
Provision,breastCancerControl
Other,12SampledWomen
Other,mostPrevalentMalignancyAmongWomenAroundWorldAreDiagnosedYear
Other,oftenRelated
Other,ptyrProteins
Other,428BreastCancerPatients
Disease,localizedDisease
Other,improvedDiagnosis
Other,investigated
Exosomes,exosomesDerivedCk19
Other,amplifications
Other,leftParietalRegion
Other,conventionalX-rayMammography
Other,otherSubtypesOfBreastCancer
Other,dopamineAgonists
Other,lymphocytes
Other,manyPatients
Other,cancerCareNetwork
Other,192Months
Other,10-foldCross-validation
Other,referral
Other,rs5743810ProAllele
Other,stat1RecruitmentToEralphaPromoterRegion
Other,rocCurveAnalysis
Other,theirOwnParticularity
Markers,mightCrcMarkers
Sequencing,appropriateSequencing
Other,bindingToBreastCancerCellsInVitro
Other,overallMedianSurvival
Mother,mustIndividualizedWithEmphasisOnOptimalCareOfMother
Other,microadenomasDataOnLong-termRemissionRate
Other,consensus-based
Other,PI3K/AKT/mTOR
DNA,dnaDamage
Other,focal
Other,773Percecnt
Other,regulated
Interval,group1
Other,expressionLevelsOfProteinsAssociatedWithEpithelial-mesenchymalTransition
Other,concomitantlyShouldAnalyzed
Incidence,incidenceTrendPlots
Other,adjuvantRadiotherapy
Other,binding
Other,roughly15000CasesPerYear
Other,2007
Other,particular
Other,detailedRoles
Other,achievedForHer2Status
Other,significantlyYounger
Other,cancerSurvivors
Other,bortezomib-inducedColdAllodynia
Other,forefront
Disease,malformation
Other,methylSpecific-multiplexLigationProbeAmplification
Other,thematicAnalysis
Other,migrationAbilitiesOfCervicalCancerCells
Other,isIdentified
Other,result
Other,chemotherapyHormonalTreatment
Other,usuallyAssociated
Other,potentialTreatmentStrategy
Other,howeverElusive
Other,numerousGene-expression-basedPrognosticSignatures
Other,Sutegorization
Other,greatBenefitsAgainstBreastCancer
Incorporation,inPresentStudyConductedBetweenMcf-7Tamoxifen-resistantLcc2CellLines
Other,reproducingKernelHilbertSpace
Resistance,cellMigration
Incorporation,associationStudy
Other,whereDeveloped
Endocrine,canEffectivelyTreatedByEndocrineTherapy
Other,robustTechnology
Other,significantlyCorrelated
Document,thatReportedInLiterature
Other,mean
Chemical,melatonin
Endocrine,hormoneReceptor-positiveTumors
Disease,kaposiSarcoma
Food,goal
Other,importantProblem
Other,decreasedRisk
Gene,HR
Collision,injury
Other,12404Patients
Obstacle,hazardRatiosWith95PercecntConfidenceIntervals
Other,twoScales
Other,m
Craniotomy,excision
Other,hasPut
Other,shanxiProvinceOfChina
Other,westernBlotAnalysis
Other,enhancedPossibility
Other,controversial
Other,erCscs
Other,subsequentMalignanciesForLung/bronchusCancerWith13PercecntSurvivorsSufferedFromSubsequentMalignancies
Other,enrolled
Craniotomy,surgicalImplantationReconstruction
Other,those
Other,only35Cases
Resistance,attenuatedCellGrowth
Other,computedTomography
Other,hasFocused
Other,clinicalCharacteristics
Other,pregnancy
Other,molecularRegulatoryNetworks
Other,harmfulorHarmlessTissues
Microenvironment,fundamentalComponentsOfTumorMicroenvironment
Other,osteopontinPeptide
Other,oestrogenReceptorPositiveIn58PercecntOfCasesPositiveIn62Percecnt
Other,83Percecnt
Endocrine,gonadotropin
Cytology,intraoperativeScrapeCytology
Other,Rituximab
Other,tumorGrowthInExperimentalModels
Resistance,theirInterestingBiologicalActivity
Other,statisticallyCorrelated
Other,real-worldSetting
Other,resources
Other,patientWithEarlyBreastCancer
Other,0.003
Other,long-term
Other,population
Other,consistentMass-spectralData
Other,omission
Other,shouldEstablished
Other,upregulation
Other,tumorBurden
Other,diseaseDiagnosis
Other,Circ-EFCAB2
Other,oftenDebated
Other,itsUsefulness
Resistance,action
Other,counseling
Lifestyle,signature
Other,4248BreastCancerPatients
Other,circularRnas
Other,trend
Other,canUsed
Other,circumferentialNarrowingOfCaecum
Obstacle,coxProportionalHazardRegressionModels
Other,manyComputerVisionApplications
Other,immunohistochemicalTechniques
Other,simpleLow-costAlternative
Other,hereditaryBreast
Other,promoterMethylationStatus
Glycosylation,glycosylation
Other,posteriorFossaOfBrain
Other,post-menopausalWomen
Other,healthExpectancyOfItspopulation
Other,moreRecommended
Other,surveillancePopulation-basedData
Other,formationOfCircularizedRna
Other,differences
Other,coxModels
Appearance,unusualCaseOfPtosis
Other,mostInvolvedSegmentsWithSuvmax39
Other,Referrals
Other,cancerClassification
Other,practicePatterns
Other,bioimpedanceAnalysis
Other,diagnosed
Other,parallelDetection
Other,frequentCancer
Other,earlyCancerDiagnosis
Other,greatPromise
Glycosylation,sixGlycosylationSites
Other,useful
Disease,invasiveBreastCancer
Other,sufficient
Other,painlessLumpInBreastAccountingFor688PercecntOfPatients
Other,independentPrognosticFactorForDfsOfEarlyStageBreastCancer
Other,dopamineAgonist
Resistance,greatPotentialOfClinicalApplication
Other,brainMetastasisFromPapillaryThyroidCarcinoma
Other,feature
Other,reverseTranscriptionQuantitativePolymeraseChainReaction
Interval,fieldOfMedicalImagesDiagnosis
Other,haveProposed
Areola,surgicalOptionsIncludingPreservationOfNippleAreolaComplex
Other,Patients
Other,Aims
Other,RNAs
Other,2060Women
Other,breastCancerCare
Other,potential
Other,psychologicalAspects
Lymphedema,lymphedemaPatients
Consensus,consensusOnAssociationBetweenExposureToDdt
Other,riskOfBreastCancerInAdulthood
Other,flowRate
Resistance,panelOf25GenesInvolvedInMechanismsOfTargetedTreatmentResistanceIn16PrimaryBreastCancersDevelopedDuringTreatment
Other,stereotacticWire-guidedBiopsy
Other,doses
Other,agents
Other,needsOfInformationSeekers
Microenvironment,pro-tumorigenicMicroenvironment
Sleep,ageOf25Years
Other,little
Other,descriptive-analyticCross-sectionalType160FemalePatientsWasselected
Relapse,reductionOfRelapse
Other,prognosesOfYoungMenWithBreastCancer
Plasticity,discoveryOfBiochemicalSignaturesMeasuredByMassSpectrometry
Other,5-yearResultsOfPhase3Isg23-01Trial
Other,materialDetection
Other,breastSurveillance
Other,abstractDataOnTheirClinicalCharacteristics
Other,indicationsForRisk-reducingSurgery
Other,therapeuticEffectsInBreastCancer
Other,post-radiationVascularLesions
Markers,standardMethodForEvaluationOfProposedPrognosticTumourMarkers
Other,functionalAssessments
Other,synthesisMethods
Capillaries,capillaries
Other,appropriateQuality
Other,essential
Literacy,definitionOfHealthLiteracy
Disease,breastTumor
Other,tract'sMetastases
Other,familyMember
Provision,overLastYearsHaveProposedAsBiomarkersForCancerDetection
Other,differentHistologicalAspects
Disease,breastCarcinoma
Other,2IndependentCohorts
Other,harmToHealthAmongRuralWomenWithIncrementalCost-effectivenessRatio
Other,differentTreatmentModalities
Infrared,nirLight
Disease,cardiacInjury
Provision,60ControlPatients
Markers,immunohistochemicalMarkers
Other,ourData
Other,improvement
Other,moreoverStronglyRecommended
Other,validated
Other,controlled
Other,napsinAIn7Percecnt
Functionality,functionality
Other,cross-validation
Incorporation,associationsBetweenChangeOfPerceivedWorkAbility
Other,Rainbow
Other,commonFinding
Other,riskOfDeath
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneInCombinationMainlyWithTrastuzumab
Food,henceMajorResearchGoal
Other,usuallyLong-term
Other,protected
Other,greatestDivergences
Other,canIncludedInDifferentialDiagnosisOfMasses
Gene,progranulin
Other,importantCornerstone
Other,genitalTract
Other,controls
Other,need
Covariance,proposedCovariance
Other,suvmax39
Other,mitosis
Other,DOACS
Other,pairedTumor
Other,growthImplicatedInTumorigenesis
Other,cylindricalGeometries
Disease,krukenbergTumors
Literacy,lowHealthLiteracy
Other,severeThreat
Other,transitionProbabilities
Other,IMR
Other,decreased
Other,PCI
Resistance,CellLines
Other,methylation
Other,patientsWithSmall-cellLungCancer
Other,recognized
Other,transcriptionFactorForkheadBoxC1
Other,axillary
Other,notablyDesigned
Other,miceConditions
Other,results
Other,mostFrequentCancerInWomenTreatedWithHormonalTherapy
Other,SUMMARY
Other,neoadjuvantChemotherapy
Document,literature
Sleep,fastDayBefore
Other,options
Exosomes,exosomesOf5-fu-resistantCrcCellsInThoseOfHighMetastaticCrcCells
Relapse,betterUnderstanding
Other,statisticallySignificantValuesAt4Cells/7MlBlood
Other,comparisonCohort
Other,differentialDiagnosis
Other,genes
Document,ddtExposure
Other,fiveGroups
Other,stillDifficult
Other,95PercecntConfidenceIntervals
Other,beta-Sitosterol-d-glucoside
Other,numericalFull-waveSimulation
Other,brain
Other,multigenePanels-with
Other,frequent
Other,PF
Metformin,metforminTreatment
Extract,average
Other,Trends
Other,salpingo-oophorectomy
Other,featureMining
Hyperglycemia,effect
Other,fiveMutationCarriers
Other,prominent
Other,publicHealthChallenge
Interval,group2
Other,hereditaryCausesOfChorea
Other,10-yearBreastCancerSurvival
Other,developmentOfGraphicallyTailoredScreeningTool
Other,positiveHer2Expression
Gene,MORC4
Other,bloodVesselsFormation
Other,knowledge
Other,years
Other,active
Other,earlyDiagnosis
Other,youngPatients
Other,tumorEasily
Other,hasIncorporated
Other,survival
Other,pregnancyFrom1959To1966
Incorporation,transferLearning
Disease,lungCancer
Lifestyle,oxphosTranscriptionalResponse
Other,calculated
Other,tissues
Other,pfBiomarkers
Baseline,proteomeScaleWithHighSelectivity
Other,increasedRonExpression
Other,simulation
Other,potentialImportanceAsModelsForHumanBreastCancer
Other,varyingAmountsOfSolidComponents
Other,overallLowOfSixCirculatingMirnas
Distance,veryRareClinicalEntityWithOnlyFewCasesHavingReportedToDate
Other,her2Status
Other,mammalianBrainTissues
Other,locoregionalDiseaseOfUnspecifiedLocation
Plasticity,sensitivityOfDrug-resistantCellsToChemotherapeutics
Other,proteinKinaseC/extracellularSignal-regulatedKinasePathway
Other,incidenceRates
Other,small
Areola,variablesPredictiveOfNippleAreolaComplexInvolvementInPatients
Other,prognosticStagingSystems
Other,locallyAdvancedBreastCancer
Other,clinico-pathologicalFeaturesOfMetastases
Other,costData
Other,27-36MillionPatients
Other,caDetection
Other,fibroblasts
Provision,medianFollow-upOf9Â·
Endocrine,commonEndocrineDisorder
Other,devastatingDiagnosis
Other,patientsWithProlactinoma
Other,onlyIndicated
Other,queried
Other,minimalRedundancyMaximalRelevanceAlgorithmAsFeatureSelectionMethods
Other,pathologicalResults
Other,furtherResearch
Drugs,resistanceToAntimitoticDrugs
Other,dissectionOfLymphNodes
Other,newValue-basedHealthcareParadigm
Membrane,membraneTypeMannoseReceptor
Other,howeverNon-ideal
Other,lisbonRegion
Other,lowIncomeCountries
Other,underlyingIncrease
Other,10Centers
Other,valueOfErbeta-targetedTherapies
Lifestyle,itsWater-bathSetup
Other,fourTypesOfBreastCancer
Other,secondValuedApproach
Other,itsMinimalSilverIonReleaseProfiles
Disease,fibroadenoma
Other,blackWomen
Other,targetedImaging-guidedPhotothermal/chemoSynergisticTumorTherapyWithHighTherapeuticEfficacy
Other,polymorphism
Other,compared
Incorporation,cohortStudy
Other,breastCancerMetastasis
Other,reverseActiveLearningForClassificationOfHealthyBreastTissue
Exposure,performance
Other,alsoObserved
Relapse,breastCancerRelapse
Other,mrnaLevels
Food,issue
Other,trastuzumabTherapyForBreastCancer
Other,regulationOfNras
Other,expressed
Other,networkOutput
Other,featureSelectionMethod
Other,denseBreasts
Other,positiveRegulatoryFeedbackLoopForFxyd3Amplification
Other,distributions
Other,terms
Other,1H
Other,anti-her2Therapies
Infrared,moreResearchLight
Resistance,applicationOfPhase-sensitiveTechniques
Other,widelyExpressed
Other,ideallyPlaced
Other,stableDrug-carrierBinding
Other,systematicCharacterization
Other,furthermoreEnhanced
Markers,diagnosticValueOfMarkers
Other,eralphaSignalling
Other,shouldGivenToGeriatricOncology
Other,indicator
Other,protectiveRoleOfRs5743810
Other,prediction
Other,painless
Areola,nippleAreolaComplexInvolvement
Other,managed
Provision,agreement
Neuropathy,relationToOccurrenceOfOsteoporosisAmongVariousEthnicGroups
Other,23Patients
Incorporation,recentDanishCohortStudy
Other,reviewed
Extract,commonCause
Modulators,protectiveEffectOfAspirinForCardiovascularEventsDuringItsConcomitantUseWithSelectiveEstrogenReceptorModulatorsInPreventionOfBreastCancer
Other,womenInWorld
Disease,infection
Other,mostPrevalentMalignancyDiagnosedInPregnancy
Other,suppressionOfBreastCancer
Other,organotropic
Other,growth
Obstacle,majorObstacle
Plasticity,sensitivityOfMda-mb-468ToChemotherapeutics
Other,cutoffValues
Disease,hereditaryDisease
Other,administered
Other,bindingSites
Other,5Percecnt
Other,higher
Other,earlyBreastCancerDetectionSystems
Other,individualRiskOfRecurrence
Other,globalHealth
Other,sustainedStableDisease
Other,microfluidicChips
Other,helaCells
Other,hospitalCohort
Relapse,medianTimeToCnsRelapseOf31Years
Cytology,fineNeedleAspirationCytology
Other,taken
Chemical,Baicalin
Other,five-yearMetastasis-free
Other,ipsilateralBreastRecurrence
Other,required
Other,relationshipBetweenStromalExpressionOfPodoplaninInInvasiveBreastCarcinoma
Other,her2-targetedTherapies
Drugs,chemotherapyDrugs
Other,moreoverAssociated
Other,adherenceToRecommendationWith95PercecntConfidenceIntervals
Areola,severeSideEffects
Other,768PercecntSamplesWithOverexpressionIn76Cases
Other,forefrontOfResearch
Interval,thanCapecitabineGroup
Other,intravoxelIncoherentMotionParameters
Other,youngMexicanWomen
Other,30Cm
Other,towaveletFilter
Other,correlationCoefficientOnMetabricTrainingSet
Disease,non-smallCellLungCancer
Other,DDTs
Other,herPresentation
Other,perceptionOfQualityOfCareProvidedByCancerCareNetworkForEarlyDetectionOfBreastCancer
Other,cancerDeathAmongWomenWorldwide
Other,moreInclined
Images,featuresFromImages
Other,critical
Other,China
Other,familialCancerClustering
Other,howeverShouldPerformed
Other,algorithm
Other,adjustingForPotentiallyConfoundingFactors
Other,studies
Other,currentUtilizedHistopathologicBiomarkers
Disease,LVEF
Other,increasedPer2Expression
Other,crucial
Other,nature
Disease,cowdenSyndrome
Other,clinicalRecords
Other,variables
Other,pathologistAnnotation
Other,product
Other,moreTargetedAdjuvantTreatments
Other,importantPhenotypicFeatureOfCdh1GermlineMutationCarriers
Other,moreRecentlyHaveDeveloped
Other,highestRateForUpperGastrointestinalCancers
Other,discussed
Other,pathologicalSpecimen
Images,high-resolutionImages
Other,thereforeRequired
Other,perfluorohexane
Other,highBurdenOfCancer
Other,mood
Other,considerations
Provision,cancerControlPlanning
Other,markedReduction
Other,mriProtocols
Other,metabolicTargetVolume
Disease,cervicalCancer
Other,covariates
Other,itsUse
Baseline,patientsWithReducedBaselineLvef
Other,willUsed
Other,tumourigenesis
Other,primaryBreastCancer
Other,Diseases
Other,TAAs
Other,10NeedContents
Other,pertinent
Endocrine,pituitaryFunction
Other,improvedDiagnostics
Other,secretion
Other,prognosticSignificanceOfNeutrophil-to-lymphocyteRatioInPatientsWithBreastCancer
Other,function
Food,differencesInAssayPerformance
Other,focus
Other,77
Resistance,vitaminDActivity
Chemical,diindolylmethane
Distance,firstCaseOfGaslessRobot-assistedNipple-sparingMastectomyInPatientWithEarlyBreastCancer
Other,short-termStrategy
Other,imaging
Disease,sexualDysfunction
Users,12331Users
Other,imbalance
Procedures,procedures
Other,increasingNumber
Other,none
Erythematous,characterizedByAcuteAppearanceWithErythematousPlaqueSometimesHotMoreOftenSituatedInPrimaryTumorVicinity
Computer,Computer
Other,phosphoinositide3-kinase
Interval,image
Other,heterogenous
Other,manifold
Other,innateImmuneSystems
Neuropathy,infiltrativeLesion
Other,sexualityMoreEvidence
Other,hasProposed
Obstacle,multivariateCoxProportionalHazardRegressionAnalysis
Articles,Articles
Other,vap-1StainingResults
Other,SVM-BRC
Other,higherDetectionRatesOfArchitecturalDistortionParticularlyInPatientsWithDenseBreastTissue
Other,estrogen-aloneArmOfWhi
Other,severalTumorSuppressorGenesInLungCancerPatients
Other,compounds
Other,followed
Mother,acuteDangerToMother
Users,users
Other,andfemales
Exosomes,exosomesCk19
Other,mostCases
Other,breastUltrasound
Provision,oneYearOfDiseaseControlWithoutDeteriorationInHerEjectionFraction
Other,its
Other,diagnosisOfCancer
Disease,HT
Other,expression
Other,itsPoorPrognosis
Disease,anxiety
Other,recentlyHaveUsedAsBiomarkers
Other,implications
Other,80
Other,rarelyMayDetected
Other,
Disease,pneumopathy
Disease,cancerGenomeAtlas
Other,thatOfMir-511
Other,associationsBetweenAspectsOfDiet
Other,2Patients
Nanoplatform,nanoplatform
Other,bLymphocyteChemoattractant
Other,performed
Appearance,99PercecntAccuracyInTermsOfClassification
Gene,VEGF-D
Other,proposedHowever
Disease,breastCancerDiagnosis
Other,broadcasted
Areola,itSideEffects
Appearance,caseOf75-year-oldPatientWithDuctalInfiltratedCarcinoma
Other,from33ObservationalStudiesExposedToTrastuzumabTherapy
Other,ai-associatedSevereTendinopathy
Cytology,cytology
Resistance,resistance
Food,symptomaticHeartFailure
Chemical,AMD3100
Other,particleSwarmOptimizationAlgorithm
Other,TIVAP
Other,sameRangeAsCasesWithoutWavelength-dependentMeasurementErrors
Other,moreDesirable
Other,a549Cells
Other,yoga
Skin,3GroupsBasedOnTertiarySolubleSt-2Level
Other,cornerstone
Other,outcomeOverCosts
Disease,choreiformMovements
Cavernous,cavernousMalformationInduction
Other,MEDLINE
Resistance,breastCancerCellMigration
Other,Myeloma
Stigmatization,stigmatization
Neuropathy,irregularHyperintenseLesion
Other,modeled
Other,nextMade
Sprays,increaseWithNumberOfSprays
Behaviours,changesInHealthBehavioursAfterBreastCancerDiagnosis
Other,developmentOfManyMetabolicDisorders
Other,malign
Other,geometries
Other,observed
Disease,OS
Other,testingDataSet
Skin,skinOriginatingFromInternalCancer
Other,p
Other,secondaryLymphoidTissueDevelopmentOfLymphocytesWithinMicrocompartmentsOfTissue
Other,contrastAgents
Other,characteristics
Other,approach
Other,Images
Other,mostFrequentlyDiagnosedCancer
Baseline,baselineSolubleSt-2Level
Other,uterineTumors
Document,document
Other,evolveTowardLessSurgery
Other,understudiedPattern
Other,considered
Other,immediateUnmetNeed
Other,theirEmergingRole
Other,significantlyCorrelatedWithOverallSurvival
Appearance,inConclusionMajorHereditaryBreastCancerGenesIrrespectiveOfAgeAtDiagnosisInJapaneseWomen
Other,specificCancerCell-relatedComponents
Other,rareSubtypeOfDllWithLimitedDataOnPatternsOfFailure
Sleep,youngAge
Other,clinicalTrials
Other,newSignalPattern
Other,created
Other,tanUsage
Other,phosphorylationOfAkt
Other,analyses
Distance,totalHemoglobinConcentration
Other,targeted
Food,heartFailureParticularly
Other,survivalData
Other,usExaminations
DNA,abnormalDnaMethylation
Other,visits
Polymorphisms,polymorphisms
Complications,riskFactorsForLateComplicationsAssociatedWithTivapthere
Collision,mostFrequentlyDiagnosedTumorInWomenWorldwideWithSignificantImpactOnMorbidity
Other,downregulatedIn
Images,images
Relapse,continuousPatternOfRelapse
Other,fiveYearRfsrate
Exosomes,exosomes
Other,992PercecntOfCases
Incorporation,multicenterStudy
Other,0.02
Other,featureSubset
Other,doublingTimeOfOccult
Other,associationOfPcdh10Methylation
Cavernous,twoCasesOfCavernousMalformationFormationYears
Other,commonOnes
Other,dataOfN=
Other,Treatment
Other,challenging
Other,lowCtnLevels
Infrared,infraredFluorescentDye
Other,recentPatternsInIncidenceRatesForMajorCancerSitesInAdults
Exposure,betterPredictionPerformance
Other,v-gCalciumChannelBindingAntibodies
Other,growingProblem
Other,cent
Other,otherImagingCharacteristics
Other,ssessedByWoundHealingAssayinAddition
Other,promising
Provision,leadingCancerSitesInOlderMales
Other,ongoingTrials
Other,scPhenotype
Other,optimalParametersInFeatureSelectionProcess
Skin,levelExamination
Collision,collisionTumorWithBreastCancerMetastasis
Other,onlyIndicative
Extract,benefit
Gene,BRCA1
DNA,dnaMethylation
Other,adverseEffects
Issues,issues
Other,histopathologicalAnalysis
Disease,tumors
Other,metastaticBreastCancer
Other,recurrence
Other,itsReceptorLocatedInManyCellsOfBody
Other,goodTolerabilitytheApatinib
Dysplasia,binaryLogisticRegressionModels
Obstacle,coxHazardRegressionModels
Other,tamoxifen-resistanceInErCancerCells
Other,subgroupVariables
Sleep,importanceOfProactivelyAddressingFertility
Gene,miR-10a
Other,receiving
Other,She
Other,commonMalignantDisease
Other,6084Years
Other,HADS
Other,240MonthsWith1SurvivalRateOf707PercecntRespectively
Other,projected
Interference,rareComplicationMostCommonlySeenInPatientsPreviouslyTreatedForBreastCancer
Other,age-basedScreeningPrograms
Other,histopathologicalDiagnostics
Other,highlySensitiveNano-biosensor
Other,itsImportantRole
Obstacle,hazardRates
Other,highIndex
Other,sialicAcidExpression
Other,uniqueFeatureInteractWithNucleicAcids
Other,five-yearLocalRecurrenceRates
Other,alternativeContrast-enhancedScreeningTools
Other,significantHigherRisk
Disease,NSCLC
Other,FPs
Other,appropriateInterpretation
Document,form
Extract,freshLeafEthanolicExtract
Other,regressionAnalyses
Other,-916
Other,combinedAnalysis
Hyperglycemia,effectOfSex
Other,directRelationship
Other,potentialClinicalBiomarker
Resistance,resistanceToExistingTherapies
Other,empiricalTreatmentsBasedOnClinical-pathologicalCharacteristicsToUseOfTargetedApproaches
Other,89FfdmCases
Other,Targeting
Other,typicalHormone-dependentTumor
Other,developmentOfMetabolicDisorders
Other,estrogenReceptor
Disease,epigeneticDysregulation
Other,clb-pt-clbProdrug
Incorporation,retrospectiveObservationalStudyOf264Her2-positiveAdvancedBreastCancer
Other,chlorambucilPlatinum
Other,heterogeneousCancerInFemalePatientsWorldwide
Chemical,bortezomib
Other,increasedMalignantPotential
Plasticity,one-waySensitivityAnalyses
Sleep,influenceOfSleepQualityOnPmInPatientsTreatedWithHt
Other,determined
Other,entities
Other,retrospectivelyReviewed
Other,multipleGeneticAberrances
Other,additionallyCorrelated
Other,assessments
Cytology,breastCancerGenetics
Nondestructive,nondestructiveTests
Dysplasia,regressionAnalysis
Other,n-typeVoltage-gatedV-gCalciumChannelBindingAntibodies
Document,nsaidExposure
Other,biomarkers
Plasticity,sensitivityAnalysesresults
Other,brd4Inhibition
Other,patientsWithHer2
Other,riskStratification
Other,clinicalBreastExamination
Other,medical
Other,160Patients
Disease,invasiveBreastCarcinoma
Other,wavelengthConsistencyIndex
Other,fpReduction
Other,195Years
Other,practitionerDecisionmaking
Other,pcdh10GenePromoterMethylationIdentifiedInDuctalCarcinoma
Other,26894Ca-vtePatientsTreatedWithAnticoagulants
Other,Diagnosis
Other,pulmonaryMetastases
Other,survivalDistributions
Other,hasInconsistent
Other,MethyLight
Other,fibroblastsAdjacent
Other,limitedNumberOfCases
Other,autonomyOfPatients
Species,patient
Nanoplatform,especiallyModifiedOntoSurfaceOfNanoplatformForActiveHer2-targing
Interference,pre-operativeAssessment
Other,interview
Other,drugTherapy
Other,6Months
Other,breastCancerTissues
Other,portugueseWomen
Other,hasSuggested
Other,sixCirculatingMirnas
Probe,nirProbe
Other,relatedResearchDataOfDiagnosisOfInoperableLocallyAdvancedBreastCancer
Applicability,clinicalApplicabilityOfOurMethodInBreastCancerImagingSetting
Other,hasAlreadyAssociatedWithDifferentCancersNon-hodgkin'sLymphoma
Other,Hsa_circ_000178
Disease,lungAdenocarcinomas
Other,overview
Other,mostCommonlyDue
Other,probableMechanisms
Other,0.007
Other,uptakeOfTrastuzumab
Appearance,receiverOperatingCharacteristic
Other,contrast-enhancedSpectralMammography
Drugs,usedDrugs
Other,screeningStrategy
Sleep,inTotalDiagnosedUnderAgeOf50
Other,differentPrognosis
Seroma,updateOnRiskFactorsForSeromaProductionAfterBreastCancerSurgery
Other,cancerCells
Other,mir-193b-3pBinding
Other,clinicopathologicalSignificance
Other,.021
Other,26/31
Macroadenomas,usuallyMacroadenomas
Other,mostPatients
Other,tissueTumors
Other,geneticMalignancyPredispositionSyndrome
Other,dose-dependentReductionInBrca1Levels
Other,selectiveBinding
Other,sevenWomen
Other,clinocopathologicOfPi3k/akt/ptenPathwayInMoroccanTripleNegativeBreastCancerPatients
Isolation,ctcIsolationTechniques
Other,therapeuticallyEffective
Other,directlyAffectedByOverexpressionDownRegulationOfManyMirnas
Other,significantConnection
Other,southernPortuguese
Other,cancerAssociatedFibroblasts
Other,medianOverallSurvival
Other,novelty
Other,comparison
Other,main
Other,mechanism
Plasticity,comparableToContrast-enhancedMriInTermsOfSensitivityAtFractionOfCost
Other,roleForPre-existingInborn-likeErrorsOfMetabolism
Other,promoterdnaMethylation
Other,inadequate
Analogs,theirPyrrolizin-5-oneAnalogs
Other,extensiveMolecular
Other,selectedPatients
Other,canExtended
Other,project
Provision,currentFollow-up
Other,breastTumorigenesis
Incorporation,inPresentWorkHasProposedForBreastCancerDiagnosis
Other,thenDefinedInReproductiveYears
Other,Validation
Other,relapseRates
Other,public
Other,resultsAberrantExpression
Other,determinantGenes
Other,synchrotronSources
Disease,erysipelatoidCarcinoma
Other,popular
Skin,level
Other,ERN
Other,omegaFattyAcids
Other,optimalCutoffValues
Other,Biomarkers
Other,18FemaleNudeMice
Other,pyrrolizin-9-one
Other,Number
Other,usuallyPerformed
Lifestyle,mitochondrialResponse
Disease,primaryTumor
Other,immune-mediatedCancer-associatedDisorders
Other,Non-linearity
Other,abundantlyPresent
Functionality,oncogenicFunctionality
Other,paradigmaticExamples
Other,adjuvantAnastrozole
Other,unbiasedRnaSequenceAnalysis
Collision,potentialImpactOnFertilityAfterTreatment
Other,shouldConsideredInEventOfAbnormalImagingFindings
Incorporation,resultsOfStudy
Other,contrastRatio
Other,increasedRisk
Other,proposedAlgorithm
Other,Co-existence
Appearance,difference
Late-stage,late-stageCancerDiagnosis
Other,treated
Chemical,tamoxifen
Other,ourAim
Other,localizedDescription
Other,differentSubtype
Distance,boneDensity
Literacy,influenceOfHealthLiteracyOnPathwayToCancerDiagnosis
Other,incidenceAmongMalignancies
Other,Pyrrolizinones
Other,denseBreastTissue
Other,state-of-the-artAlgorithms
Lifestyle,proposedTotal-variationSchemeWithSpatially-varyingAnisotropicWeightingCompensateForGeometricBiasFromLimitedAngleImagingSetup
Other,positive
Other,compounds19a
Gene,microRNA-22
Other,oneExtraVisit
Other,strongContrast
Other,examination
Other,hypomethylated
Other,tailoredConsiderations
Relapse,riskOfBreastRelapse
Other,humanLife
Other,profile
Other,roleOfEstrogens
Other,Literature
Disease,cardiotoxicity
Other,mostPrevalentTumorFollowedByLow-gradeBNon-hodgkinLymphoma
Other,collected
Other,biologicallyDifferentDisease
Other,serumSamplesFromCancerPatients
Other,properFunctioningOfSkeletalSystem
Other,acceptableSafetyMargins
Other,definedSubtype
Other,volumetricMeasurementSystem
Other,all
Other,nsclcPatientsAssociatedWithShorterOverallSurvival
Document,mouseModel
Other,neededAcrossCareContinuumEspeciallyInLow-resourceSettings
Other,rnaKnockdown
Functionality,oncogenicFunctionalityOfSpc24InBreastCancerProgression
Other,unusual
Other,following
Other,pi3k-akt-mediatedMitochondrialSignalingPathwayTumorSuppressorMir-10a
Other,16PrimaryBreastCancers
Resistance,capacity
Species,Fisher
Other,Cryopreservation
Other,chemotherapyRegimens
Other,mStage
Other,preventionOfDiagnosedBreastCancerInEstrogen-aloneArmOfWhi
Other,cancerMolecularDiagnosis
Other,efficientSignaturesForClinicalDiagnosis
Other,sosValues
Other,confidentDiagnoses
Collision,recurrentWords
Other,byDevelopmentOfHybridomaTechnologyHaveProducedInManyLaboratories
Other,tests
Interval,fieldOfBreastCancerDetection
Other,breastCancerConfinedWithinMammaryDuctsSurrounded
Endocrine,adjuvantEndocrineHormonalTherapy
Other,lossOf020Quality-adjustedLifeYears
Other,shouldGiven
Other,potentialSourcesOfVariance
Other,interest
Lymphedema,unilateralBreastCancer-relatedLymphedema
Other,diffuse
Other,recurrence-free-survival
Other,proportion
Other,expressionOfOtherBiomarkers
Other,strongAssociation
Other,alsoAssessed
Other,potentAnticancerEffects
Other,focalNeurologicDeficit
Resistance,capacityForEarlyDiagnosisOfBreastCancer
Other,Utilization
Other,mainChallenge
Other,physicallyActive
Other,receivedWithoutSurfaceModification
Issues,issuesOfExistingContrastAgents
Other,forwardProblem
Other,anticipated
Other,cm
Other,standardAxillarySurgery
Other,questionnaireAdministeredOnJapan'sLargestCancerInformationWebsite
Other,un-recognized
Other,mayNecessary
Other,chosen
Other,digitalBreastTomosynthesis
Other,21Months
Other,tumorNecrosisFactor
Other,enforcedExpression
Other,tenfoldCross-validationMatthew
Other,two-thirdsOfBreastCancerCases
Other,markedlyDownregulated
Other,their
Species,nudeMice
Other,greater
Interval,after6Months'TherapySignificantlyHigherIn3rdTertiaryGroup
Other,increase
Other,onEsophagogastroduodenoscopyIdentifiedInAntrum
Other,onlyWomen
Oestrogen,oestrogenReceptorAlpha
Other,interaction
Other,especiallyFrequentLateRelapsesInCnsBreast
Other,Findings
Lifestyle,lifestyleFactors
Areola,sideEffectsOfBreastCancerTherapiesIncludingHotFlushes
Other,consultations
Other,subtyped
Other,intelligentTechniques
Other,shouldAdministered
Provision,provision
Other,pathway
Skin,dichlorofluoresceinLevel
Extract,cause
Other,status
Other,careProvider
Relapse,betterOs
Gene,Drp1
Other,0.011
Other,contrastEnhancement
Other,initialResults
Other,rnaSequenceAnalysis
Procedures,interventionalProcedures
Other,stratification
Other,presentation
Disease,micrometastasis
Other,safety
Other,computedTomographyOfBrain
Other,mostPrevalentCancer
Other,theirSelection
Other,44Percecnt
Other,125DogSeraSamplesIncluding75MammaryTumourSera
Other,shouldProceede
Other,Investigation
Other,data
Markers,solubleMarkers
Appearance,oneCase
Other,volume
Other,13PercecntOfDeaths
Disease,metastases
Other,mastectomy
Interval,g1/s-phaseCellCycleArrest
Other,brcc3ExpressionLevels
Other,world
Other,promisingSupplements
Regions,enhancerRegions
Other,expressionInBreastCancer
Other,crcPatients
Other,high
Other,importantForDiagnosis
Other,drugDecay
Interference,itsWidespreadImplementation
Other,Europe
Other,found
Other,antibodies
Other,useOfAdvancedImagingExaminations
Other,variableMolecularMechanismsOfCarcinogenesis
Relapse,betterUnderstandingOfRisksAssociatedWithM
Other,YS
Other,MicroRNAs
Disease,breastCancerProgression
Resistance,freshLeafEthanolicExtract-treatedMda-mb-231CellDeath
Other,cancerSignaling
Other,brca1Wild-typeTripleNegativeBreastCancer
Exosomes,problemOfDiscriminationOfExosomes
Disease,UC
Other,aberrantMethylationDetection
Distance,firstTime
NSAID,nsaidUsers
Obstacle,adjustedHazardRatio
Other,13
Other,retrospectiveStudies
Other,third-degree
Other,percecnt
Probe,specificEralpha-targetedProbe
Other,effects
Other,therapeuticBenefits
Interval,absence
Other,olderWomen
Other,priorities
Other,tumorCells
Plasticity,sensitivityOf786PercecntRespectively
Other,RT
Other,able
Other,formulation
Other,inMultivariateModelsRelatedToPerformanceStatus
Disease,pain
Other,supplementalScreening
Other,generalBreastCancerPopulation
Metformin,metformin
Other,masses
Other,specificCircumstances
Interval,groupProfilesForSubgroup
Other,blood
Other,CTIBL
Other,breastCancerStudies
Other,thusMeaningful
Other,score
Other,complexSemisolidMassesWithVaryingAmountsOfSolidComponents
Other,48Years
Other,coding
Other,appropriateAllocationOfResearchFunding
Other,inexpensiveTechnique
Other,biomarker
Other,increased
Other,AS
Other,mutations
Other,similarSeriousAdverseEvents
Other,brd4Regulation
Other,postmenopausalPatient
Other,differentProtocols
Other,lymphaticInvasion
Other,65Months
Other,double-maintenanceTherapy
Skin,aromataseInhibitor-inducedBoneLoss
Other,onlySubgroupWithProgesteroneReceptor
Other,oneRegion
Other,theirExperiencesLivingWithSister
Other,administrationOfNeoadjuvant
Other,dataOn108Pb-dllPatientsFrom21ChineseMedicalCenters
Other,deep-CNN
Other,subgroupOfMacroprolactinomas
Other,healthcareCost
Other,symptoms
Other,undergoing
Other,centralImplantedVenousAccessDevices
Other,individuals
Other,limited
Other,lowRiskLesions
Sleep,documentationOfPatientAge
Other,fourGroups
Other,mitochondrialFission
Other,node
Other,prophylacticBilateralSalpingo-oophorectomy
Other,records
Other,geneticChanges
Other,thusAimed
Other,methods
Other,howeverStillUnclear
Other,syndromes
Disease,breastCancers
Interval,youngerAgeGroup
Other,Comparisons
Species,Women
Other,utilization
Other,ranging
Distance,firstPatientsWithPathologicallyTumor-freeNodes
Other,healthCenters
Membrane,combinedPanel
Other,variousArtifactsIntroducedDuringSlidePreparation
Other,cancerType
Other,numberOfSegmentInvolved
Areola,sideEffects
Other,couldIndependentPrognosticBiomarkerForMPatients'Outcomes
Document,balfContent
Other,pre
Document,balfContentOfProgranulinIn46NsclcPatientsBeforeChemotherapy
Other,breastSurvival
Other,tissueStorageTime
Food,followedFromDateOfFirstDiagnosisOfAdToEndOf2013
Provision,disturbance
Other,concerns
Granuloma,neuroma
Other,multiparametricMri
Other,survivalTime
Skin,solubleSt-2Level
Other,barcodeMode
Interval,highlyDiverseGroupOfMalignantNeoplasiaWithPoorOutcome
Other,manyWays
Other,shaped
Other,conservativeTreatment
Other,375Percecnt
Other,subjectiveRisk
Other,decades
Other,importantRoles
Other,possibility
Other,Management
Other,dramaticallyIncreasedAmount
Areola,pulmonaryEverolimusSideEffects
Interference,mostFrequentLateComplication
Other,845Percecnt
Other,targetingFxyd3-mediatedPathway
Endocrine,endocrineResistance
Other,hugeImprovement
Sleep,youngerAge
Other,policyActions
Other,20PercecntForGata3
Other,examined
Other,mostPowerfulTool
Incorporation,perceivedWorkAbility
Other,haveBackbone
Other,thirdInTermsOfSpecificMortality
Other,peripheralBloodSamples
Other,cancerProgression
Resistance,inhibitionOfCellProliferation
Other,mitosisDyingByMitoticCatastrophe
Other,multivariateModelsAdjustedForIncome
Extract,womenOfAverageRiskWithDenseBreasts
Other,amino-terminalFragment
Other,moreoverPoor
Other,tumorFluid
Other,kmt2aFusionGeneTranscripts
Distance,firstTimeIn1984
Other,newCancerCases
Other,presence
Other,higherResolution
Other,characterization
Incorporation,prospectiveNestedCase-controlStudy
Other,C
Other,commonCancer
Other,signalIntensity
Other,flankingCgi
Other,clinicalDiagnosticPathways
Distance,firstDataOnPre-diagnosisConcentrationsOfSrankl
Other,large
Other,insights
Other,diseaseDefinedByTumor
Other,peopleWithDiagnosisOfCancer
Other,thereforeHasAppliedToEarlyIdentification
Other,signatures
Other,routineUseByFoodAdministrationIn2002
HER-2,adultsWithHer-2PositiveBreastCancer
Other,functions
Other,advancedBreastCancerBearingMutations
Other,Probes
Other,aspects
Other,highGlut1Expression
Other,cancerStaging
Other,7051UnselectedBreastCancerPatientsOfJapaneseAncestry
Other,bleedingRates
Other,furtherStudies
Other,debated
Other,treatments
Other,timingOfChemotherapyForBreastCancersWithDifferentMolecularBackgrounds
Other,transformed
Complexes,phosphotyrosineProteinComplexes
Disease,malignantPleuralEffusion
Other,stable
Other,peakInRecurrenceRisk
Other,ourProposedMethod
Other,extremeLearningMachineClassification
Other,low-molecular-weightHeparin
Other,prognosticValue
Other,transcoelomic
Other,fundamentalComponents
Other,medicalStatus
Resistance,multidrugResistance
Other,definiteDiagnosisParticularlyInSmallBiopsies
Other,evaluated
Interval,keyCircadianClockGene
Interval,cellCycleRegulators
Collision,impactOfStableKnockdownOfSmarcad1OnHumanBreastCancerCellProgression
Other,SPIO
Other,involvement
Other,dualRoleOfL-3InBl1-subtypeTriple-negativeBreastCancer
Collision,greatClinicalImpactForTumorDiagnosis
Disease,neuropathies
Other,roleOfImage-basedTextureFeaturesAsNoninvasivePrognosticBiomarkers
DNA,aberrantDnaMethylation
Other,based
Other,reporterAssays
Other,achieved
Other,OR
Other,bilateralInvolvement
Other,couldDeveloped
Other,510YearsAfterSurgery
Food,toEndDevelopedWithDrugToAntibodyRatioOf329
Other,challenge
Other,postmenopausalwomen
Other,importantNumber
Other,substantialImprovements
Other,assessed
Other,miR-34s
Almaty,almatyCity
Other,differentialExpression
Other,it
Other,sensitiveCells
Other,survivalOfCellsInVitroAndInVivo
Other,localRecurrence
Other,significantlyUp-regulated
Other,50
Other,clinicalPicture
Document,zebrafishTumorModel
Other,standardizedImagingProtocol
Other,Applications
Other,summarisedIn2018WorldCancerResearchFund/americanInstituteForCancerResearchReportGlobalPerspective
Other,pathologicallyTumor-freeNodes
Other,inclusionCriteria
Other,research
Other,largestCancerInformationWebsite
Other,canines
Other,3PreviousMalignancies
Other,identified
Other,amongYoungerPeopleCommon
Other,colorectalTissue
Other,regulationOfEmtProgressionOfSnaiFamilyMembers
Other,importantOfSpc24ForClinicalTreatment
Other,rapidBreast-cancer-tissueDiagnosis
Other,up-regulated
Other,fused
Other,roboticSystem
Plasticity,highSensitivity
Interference,shouldEstablishedBetweenScreeningWithImplementationOfRobustQualityAssurance
Obstacle,catheter-relatedObstruction
Other,breastCancerTreatment
Other,tnmStage
Other,respectivelyFound
Other,management
Other,Belgium
Other,canHeavilyInfluenced
Other,therebyFrequentlyNeglected
Other,thereforeUrgentlyNeeded
Other,variousEnvironments
Other,vap-1NegativeStaining
Other,related
Other,secretionOfTumorNecrosisFactor
Other,contralateralBreast
Other,findingsFromStudies
Other,reported
Other,female-specific
Food,mtorInhibitorEverolimus
Provision,site-specificBindingLeadingToImprovedCancerTreatmentWithMinimalRisksToNormalCells
Other,platform
Other,selectiveAccumulationOfFluorescentOsteopontinInVitroAndInVivo
Other,protectiveFactors
Other,completionOfReproductivePlans
Other,haveConducted
Other,inCanadaOfferedInOrganizedPrograms
Other,usedAtOurInstitutionForSelectPatientsWithGoodOutcomes
Other,differentiationBetweenBreastCancerInVariousSubtypesOfBreastCancer
Other,sosReconstruction
Other,oncogenes
Other,itInvolvesInManyCrucialMetabolicProcesses
Gene,CK19
Resistance,capabilitiesOfCellInvasion
Disruption,intrinsicDisruption
Extract,treatmentBenefitWithTrastuzumabTherapyForBreastCancer
Other,widelyKnown
Other,group-basedTrajectoryModelling